Miguel Ángel González‐gay
#124,802
Most Influential Person Now
Miguel Ángel González‐gay's AcademicInfluence.com Rankings
Miguel Ángel González‐gaybiology Degrees
Biology
#7820
World Rank
#10795
Historical Rank
Genetics
#757
World Rank
#849
Historical Rank
Neuroscience
#1042
World Rank
#1084
Historical Rank

Download Badge
Biology
Miguel Ángel González‐gay's Degrees
- PhD Genetics Complutense University of Madrid
- Masters Biology Complutense University of Madrid
- Bachelors Biotechnology Complutense University of Madrid
Similar Degrees You Can Earn
Why Is Miguel Ángel González‐gay Influential?
(Suggest an Edit or Addition)Miguel Ángel González‐gay's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Genetics of rheumatoid arthritis contributes to biology and drug discovery (2013) (1877)
- EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis (2009) (1304)
- EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update (2016) (865)
- Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci (2013) (689)
- High density genetic mapping identifies new susceptibility loci for rheumatoid arthritis (2012) (595)
- Epidemiology of giant cell arteritis and polymyalgia rheumatica. (2009) (471)
- Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus (2010) (377)
- HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis. (2007) (376)
- Rheumatoid arthritis: a disease associated with accelerated atherogenesis. (2005) (361)
- Association of a functional single-nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with rheumatoid arthritis and systemic lupus erythematosus. (2005) (342)
- Leptin in the interplay of inflammation, metabolism and immune system disorders (2017) (328)
- High-grade C-reactive protein elevation correlates with accelerated atherogenesis in patients with rheumatoid arthritis. (2005) (283)
- Increased Prevalence of Severe Subclinical Atherosclerotic Findings in Long-Term Treated Rheumatoid Arthritis Patients Without Clinically Evident Atherosclerotic Disease (2003) (266)
- High prevalence of subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. (2007) (256)
- Obesity, Fat Mass and Immune System: Role for Leptin (2018) (252)
- Active but transient improvement of endothelial function in rheumatoid arthritis patients undergoing long-term treatment with anti-tumor necrosis factor alpha antibody. (2004) (249)
- Carotid intima-media thickness predicts the development of cardiovascular events in patients with rheumatoid arthritis. (2009) (231)
- Biopsy-negative giant cell arteritis: clinical spectrum and predictive factors for positive temporal artery biopsy. (2001) (230)
- Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1 (2015) (214)
- Carotid ultrasound is useful for the cardiovascular risk stratification of patients with rheumatoid arthritis: results of a population-based study (2013) (212)
- Endothelial dysfunction in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. (2007) (212)
- Aortic Aneurysm and Dissection in Patients With Biopsy-Proven Giant Cell Arteritis From Northwestern Spain: A Population-Based Study (2004) (211)
- Strokes at Time of Disease Diagnosis in a Series of 287 Patients With Biopsy-Proven Giant Cell Arteritis (2009) (205)
- Henoch-Schönlein purpura in children and adults: clinical differences in a defined population. (2002) (204)
- The epidemiology of the primary systemic vasculitides in northwest Spain: implications of the Chapel Hill Consensus Conference definitions. (2003) (203)
- Anti-tumor necrosis factor-alpha blockade improves insulin resistance in patients with rheumatoid arthritis. (2006) (197)
- Could HLA-DRB1 be the protective locus in rheumatoid arthritis? (1995) (191)
- HLA-DRB1 status affects endothelial function in treated patients with rheumatoid arthritis. (2003) (186)
- Giant Cell Arteritis in Northwestern Spain: A 25-Year Epidemiologic Study (2007) (178)
- Influence of Traditional Risk Factors of Atherosclerosis in the Development of Severe Ischemic Complications in Giant Cell Arteritis (2004) (178)
- Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis. (2014) (177)
- Rheumatoid arthritis and metabolic syndrome (2014) (170)
- Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis (2017) (169)
- Epidemiology of the vasculitides. (2001) (167)
- Fine mapping seronegative and seropositive rheumatoid arthritis to shared and distinct HLA alleles by adjusting for the effects of heterogeneity. (2014) (167)
- Identification of Novel Genetic Markers Associated with Clinical Phenotypes of Systemic Sclerosis through a Genome-Wide Association Strategy (2011) (158)
- Genetic markers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheumatica. (2003) (156)
- Protection against anti-citrullinated protein antibody-positive rheumatoid arthritis is predominantly associated with HLA-DRB1*1301: a meta-analysis of HLA-DRB1 associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in fou (2010) (151)
- The High Prevalence of Subclinical Atherosclerosis in Patients With Ankylosing Spondylitis Without Clinically Evident Cardiovascular Disease (2009) (144)
- Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies. (2019) (141)
- Insulin resistance in rheumatoid arthritis: the impact of the anti‐TNF‐α therapy (2010) (140)
- Association of the C8orf13-BLK region with systemic sclerosis in North-American and European populations. (2010) (139)
- Validated methods for assessment of subclinical atherosclerosis in rheumatology (2012) (135)
- A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility. (2015) (133)
- Cardiovascular risk stratification in rheumatic diseases: carotid ultrasound is more sensitive than Coronary Artery Calcification Score to detect subclinical atherosclerosis in patients with rheumatoid arthritis (2013) (131)
- Giant cell arteritis: disease patterns of clinical presentation in a series of 240 patients. (2006) (131)
- Carotid intima media thickness in rheumatoid arthritis as compared to control subjects: a meta-analysis. (2011) (130)
- Correlation between endothelial function and carotid atherosclerosis in rheumatoid arthritis patients with long-standing disease (2011) (130)
- Epidemiology of biopsy proven giant cell arteritis in northwestern Spain: trend over an 18 year period (2001) (130)
- TNFA -308 (rs1800629) polymorphism is associated with a higher risk of cardiovascular disease in patients with rheumatoid arthritis. (2011) (129)
- Clinical Spectrum Time Course in Anti Jo-1 Positive Antisynthetase Syndrome (2015) (128)
- Relapses and Recurrences in Giant Cell Arteritis: A Population-Based Study of Patients With Biopsy-Proven Disease From Northwestern Spain (2011) (127)
- Echocardiographic and Doppler findings in long-term treated rheumatoid arthritis patients without clinically evident cardiovascular disease. (2004) (124)
- A loss-of-function variant of PTPN22 is associated with reduced risk of systemic lupus erythematosus. (2008) (124)
- Systemic Sclerosis in Northwestern Spain: A 19-year Epidemiologic Study (2008) (124)
- Tocilizumab in giant cell arteritis: Multicenter open-label study of 22 patients. (2015) (121)
- Metabolic Syndrome in Rheumatoid Arthritis (2013) (120)
- Association of STAT4 with rheumatoid arthritis: a replication study in three European populations. (2008) (118)
- Cardiovascular Safety During Treatment With Baricitinib in Rheumatoid Arthritis (2019) (116)
- Short-term improvement of endothelial function in rituximab-treated rheumatoid arthritis patients refractory to tumor necrosis factor alpha blocker therapy. (2008) (115)
- Cardiovascular risk assessment in patients with rheumatoid arthritis: The relevance of clinical, genetic and serological markers. (2016) (115)
- Endothelial dysfunction, carotid intima-media thickness, and accelerated atherosclerosis in rheumatoid arthritis. (2008) (114)
- Abatacept in patients with rheumatoid arthritis and interstitial lung disease: A national multicenter study of 63 patients. (2018) (113)
- Cardiovascular magnetic resonance in rheumatology: Current status and recommendations for use. (2016) (112)
- Cardiovascular safety findings in patients with rheumatoid arthritis treated with tofacitinib, an oral Janus kinase inhibitor. (2016) (111)
- Effect of anti-tumor necrosis factor alpha therapy on the progression of subclinical atherosclerosis in severe rheumatoid arthritis. (2006) (108)
- Influence of anti-TNF-alpha infliximab therapy on adhesion molecules associated with atherogenesis in patients with rheumatoid arthritis. (2006) (107)
- High-density genotyping of immune loci in Koreans and Europeans identifies eight new rheumatoid arthritis risk loci. (2015) (106)
- Adipokines: Linking metabolic syndrome, the immune system, and arthritic diseases. (2019) (102)
- Adipokines and inflammation: is it a question of weight? (2018) (102)
- Rheumatic Manifestations of Infective Endocarditis in Non-Addicts: A 12-Year Study (2001) (102)
- Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: Baseline data of the CARMA Project. (2015) (101)
- A functional variant of vascular endothelial growth factor is associated with severe ischemic complications in giant cell arteritis. (2005) (101)
- Evidence of association of macrophage migration inhibitory factor gene polymorphisms with systemic lupus erythematosus (2006) (101)
- A systemic sclerosis and systemic lupus erythematosus pan-meta-GWAS reveals new shared susceptibility loci. (2013) (99)
- Temporal arteritis in a northwestern area of Spain: study of 57 biopsy proven patients. (1992) (97)
- Can suppression of inflammation by anti-TNF prevent progression of subclinical atherosclerosis in inflammatory arthritis? (2014) (96)
- Cardiovascular disease in inflammatory rheumatic diseases. (2016) (96)
- A1298C polymorphism in the MTHFR gene predisposes to cardiovascular risk in rheumatoid arthritis (2010) (92)
- Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course (2019) (89)
- Giant Cell Arteritis: Epidemiology, Diagnosis, and Management (2010) (88)
- Efficacy of Anakinra in Refractory Adult-Onset Still's Disease (2015) (88)
- Inducible but not endothelial nitric oxide synthase polymorphism is associated with susceptibility to rheumatoid arthritis in northwest Spain. (2004) (87)
- Association of giant cell arteritis and polymyalgia rheumatica with different tumor necrosis factor microsatellite polymorphisms. (2000) (87)
- Identification of CSK as a systemic sclerosis genetic risk factor through Genome Wide Association Study follow-up. (2012) (87)
- ERAP2 is associated with ankylosing spondylitis in HLA-B27-positive and HLA-B27-negative patients (2015) (86)
- Adult-onset Still's disease: Advances in the treatment. (2016) (85)
- Anti-TNF-alpha therapy modulates resistin in patients with rheumatoid arthritis. (2008) (83)
- Effects of tofacitinib and other DMARDs on lipid profiles in rheumatoid arthritis: implications for the rheumatologist. (2016) (83)
- Tocilizumab in refractory aortitis: study on 16 patients and literature review. (2014) (83)
- Audiovestibular Manifestations in Giant Cell Arteritis: A Prospective Study (2003) (82)
- Inflammation and lipid profile in rheumatoid arthritis: bridging an apparent paradox (2014) (81)
- Recommendations for the treatment of anti-melanoma differentiation-associated gene 5-positive dermatomyositis-associated rapidly progressive interstitial lung disease. (2020) (81)
- NFKB1-94ATTG ins/del polymorphism (rs28362491) is associated with cardiovascular disease in patients with rheumatoid arthritis. (2012) (80)
- The PTPN22 R263Q polymorphism is a risk factor for rheumatoid arthritis in Caucasian case-control samples. (2011) (80)
- Association of ferritin autoantibodies with giant cell arteritis/polymyalgia rheumatica (2012) (79)
- Analysis of a functional BTNL2 polymorphism in type 1 diabetes, rheumatoid arthritis, and systemic lupus erythematosus. (2005) (79)
- HLA-DRB1 alleles encoding an aspartic acid at position 70 protect against development of rheumatoid arthritis. (2001) (78)
- Prevalence of hepatitis C serum antibody in autoimmune diseases. (2009) (77)
- A genome-wide association study of rheumatoid arthritis without antibodies against citrullinated peptides (2013) (77)
- Anti-TNF-α therapy in refractory uveitis associated with sarcoidosis: Multicenter study of 17 patients. (2015) (77)
- HO-1 promoter polymorphism associated with rheumatoid arthritis. (2007) (76)
- Recommendations for the management of cardiovascular risk in patients with rheumatoid arthritis: scientific evidence and expert opinion. (2014) (76)
- Interleukin 1 receptor antagonist gene polymorphism is associated with severe renal involvement and renal sequelae in Henoch-Schönlein purpura. (2002) (76)
- Polymyalgia rheumatica (2017) (75)
- Listeria monocytogenes infection in patients with rheumatic diseases on TNF-alpha antagonist therapy: the Spanish Study Group experience. (2008) (74)
- Henoch-Schönlein Purpura in Northern Spain Clinical Spectrum of the Disease in 417 Patients From a Single Center (2014) (74)
- Different gene loci within the HLA-DR and TNF regions are independently associated with susceptibility and severity in Spanish rheumatoid arthritis patients. (2000) (74)
- Biomechanics, obesity, and osteoarthritis. The role of adipokines: When the levee breaks (2017) (74)
- A replication study confirms the association of TNFSF4 (OX40L) polymorphisms with Systemic Sclerosis in a large European cohort (2010) (73)
- Interleukin 8 gene polymorphism is associated with increased risk of nephritis in cutaneous vasculitis. (2002) (73)
- Molecular Relationships among Obesity, Inflammation and Intervertebral Disc Degeneration: Are Adipokines the Common Link? (2019) (70)
- Henoch-Schönlein Purpura in Northern Spain (2014) (70)
- Protective role of major histocompatibility complex class II Ebd transgene on collagen-induced arthritis (1994) (69)
- Giant cell arteritis: laboratory tests at the time of diagnosis in a series of 240 patients. (2006) (68)
- Genetics of immunoglobulin-A vasculitis (Henoch-Schönlein purpura): An updated review. (2018) (68)
- Genetic epidemiology: Giant cell arteritis and polymyalgia rheumatica (2001) (68)
- Correction: Identification of Novel Genetic Markers Associated with Clinical Phenotypes of Systemic Sclerosis through a Genome-Wide Association Strategy (2011) (67)
- The Spectrum of Paraneoplastic Cutaneous Vasculitis in a Defined Population (2013) (66)
- Anti-IL6-Receptor Tocilizumab in Refractory and Noninfectious Uveitic Cystoid Macular Edema: Multicenter Study of 25 Patients. (2019) (65)
- Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice. (2019) (65)
- Progranulin as a biomarker and potential therapeutic agent. (2017) (65)
- Systemic Lupus Erythematosus in Northwestern Spain: A 20-Year Epidemiologic Study (2011) (64)
- The erythrocyte sedimentation rate is associated with the development of visual complications in biopsy-proven giant cell arteritis. (2008) (64)
- Visfatin is not associated with inflammation or metabolic syndrome in patients with severe rheumatoid arthritis undergoing anti-TNF-alpha therapy. (2010) (63)
- Interferon-gamma gene microsatellite polymorphisms in patients with biopsy-proven giant cell arteritis and isolated polymyalgia rheumatica. (2004) (63)
- Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune Diseases (2020) (63)
- Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication study (2012) (62)
- Interleukin-6 gene -174 promoter polymorphism is associated with endothelial dysfunction but not with disease susceptibility in patients with rheumatoid arthritis. (2009) (62)
- Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group (2017) (62)
- Meta-analysis of Immunochip data of four autoimmune diseases reveals novel single-disease and cross-phenotype associations (2018) (62)
- Anti-TNF-α therapy does not modulate leptin in patients with severe rheumatoid arthritis (2009) (62)
- Analysis of IRF5 gene functional polymorphisms in rheumatoid arthritis. (2006) (61)
- Predictors of cerebrovascular accidents in giant cell arteritis in a defined population. (2004) (61)
- Asymptomatic hyperuricemia and serum uric acid concentration correlate with subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease. (2009) (61)
- Genetics of vasculitis (2015) (60)
- Interleukin 1beta gene polymorphism association with severe renal manifestations and renal sequelae in Henoch-Schönlein purpura. (2004) (60)
- Anti-TNF-Alpha-Adalimumab Therapy Is Associated with Persistent Improvement of Endothelial Function without Progression of Carotid Intima-Media Wall Thickness in Patients with Rheumatoid Arthritis Refractory to Conventional Therapy (2012) (60)
- Particle Repositioning Maneuver Versus Brandt-Daroff Exercise for Treatment of Unilateral Idiopathic BPPV of the Posterior Semicircular Canal: A Randomized Prospective Clinical Trial With Short- and Long-Term Outcome (2012) (60)
- IL-6 promoter polymorphism at position -174 modulates the phenotypic expression of polymyalgia rheumatica in biopsy-proven giant cell arteritis. (2002) (59)
- HLA-DRB1*01 association with Henoch-Schönlein purpura in patients from northwest Spain. (2001) (59)
- Giant Cell Arteritis and Polymyalgia Rheumatica: an Update (2015) (59)
- A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis. (2017) (58)
- Association of FCGR2A and FCGR2A-FCGR3A haplotypes with susceptibility to giant cell arteritis (2006) (57)
- Seronegative rheumatoid arthritis in elderly and polymyalgia rheumatica have similar patterns of HLA association. (2001) (57)
- Study of functional variants of the BANK1 gene in rheumatoid arthritis. (2009) (56)
- Relapses in patients with Henoch–Schönlein purpura (2016) (56)
- Tocilizumab in uveitis refractory to other biologic drugs: a study of 3 cases and a literature review. (2014) (56)
- Human leukocyte antigen-DRB1*1502 (DR2Dw12) transgene reduces incidence and severity of arthritis in mice. (1996) (55)
- Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy (2017) (55)
- Predictors of positive 18F-FDG PET/CT-scan for large vessel vasculitis in patients with persistent polymyalgia rheumatica. (2019) (54)
- A new immunometabolic perspective of intervertebral disc degeneration (2021) (54)
- Identification of a new putative functional IL18 gene variant through an association study in systemic lupus erythematosus. (2009) (53)
- Giant cell arteritis without clinically evident vascular involvement in a defined population. (2004) (53)
- Polymyalgia manifestations in different conditions mimicking polymyalgia rheumatica. (2000) (53)
- Steroid therapy improves endothelial function in patients with biopsy-proven giant cell arteritis. (2006) (52)
- A combined large-scale meta-analysis identifies COG6 as a novel shared risk locus for rheumatoid arthritis and systemic lupus erythematosus (2016) (51)
- New insight on the Xq28 association with systemic sclerosis (2013) (51)
- Polymorphism at codon 469 of the intercellular adhesion molecule-1 locus is associated with protection against severe gastrointestinal complications in Henoch-Schönlein purpura. (2001) (51)
- Tocilizumab in patients with Takayasu arteritis: a retrospective study and literature review. (2016) (50)
- Association of a CD24 gene polymorphism with susceptibility to systemic lupus erythematosus. (2007) (49)
- Anti‐tumor necrosis factor‐alpha therapy improves endothelial function and arterial stiffness in patients with moderate to severe psoriasis: A 6‐month prospective study (2016) (47)
- Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Behçet's Disease. (2018) (47)
- Atherosclerosis in patients with biopsy-proven giant cell arteritis. (2007) (47)
- Fever in biopsy-proven giant cell arteritis: clinical implications in a defined population. (2004) (46)
- Short-term improvement following dry needle stimulation of tender points in fibromyalgia (2014) (46)
- Identification of the PTPN22 functional variant R620W as susceptibility genetic factor for giant cell arteritis (2013) (46)
- Interleukin 12 (IL12B) and interleukin 12 receptor (IL12RB1) gene polymorphisms in rheumatoid arthritis. (2005) (46)
- Timing of onset affects arthritis presentation pattern in antisyntethase syndrome. (2018) (46)
- TNF-alpha antagonist therapy improves insulin sensitivity in non-diabetic ankylosing spondylitis patients. (2012) (46)
- Natural Molecules for Healthy Lifestyles: Oleocanthal from Extra Virgin Olive Oil. (2019) (45)
- Definition and epidemiology (2016) (45)
- Association between functional haplotypes of vascular endothelial growth factor and renal complications in Henoch-Schönlein purpura. (2006) (45)
- Audiovestibular Manifestations in Patients With Limited Systemic Sclerosis and Centromere Protein-B (CENP-B) Antibodies (2008) (45)
- Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study. (2017) (44)
- Ischemic heart disease in patients from Northwest Spain with biopsy proven giant cell arteritis. A population based study. (2005) (44)
- A genome-wide association study suggests the HLA Class II region as the major susceptibility locus for IgA vasculitis (2017) (43)
- The effect of biologic therapy different from infliximab or adalimumab in patients with refractory uveitis due to Behçet's disease: results of a multicentre open-label study. (2016) (43)
- Deletion of LCE3C and LCE3B is a susceptibility factor for psoriatic arthritis: a study in Spanish and Italian populations and meta-analysis. (2011) (43)
- Anti-TNF-alpha therapy does not modulate leptin in patients with severe rheumatoid arthritis. (2009) (43)
- Risk factors associated with renal lithiasis during uricosuric treatment of hyperuricemia in patients with Gout (2010) (43)
- HLA-B35 association with nephritis in Henoch-Schönlein purpura. (2002) (43)
- Prevalence of HLA-B27 and subtypes of HLA-B27 associated with ankylosing spondylitis in Galicia, Spain. (2004) (43)
- The effect of JAK1/JAK2 inhibition in rheumatoid arthritis: efficacy and safety of baricitinib. (2019) (43)
- SCORE and REGICOR function charts underestimate the cardiovascular risk in Spanish patients with rheumatoid arthritis (2013) (43)
- Short-term efficacy of topical capsaicin therapy in severely affected fibromyalgia patients (2013) (42)
- Study of Association of CD40-CD154 Gene Polymorphisms with Disease Susceptibility and Cardiovascular Risk in Spanish Rheumatoid Arthritis Patients (2012) (42)
- CCR5Δ32 variant and cardiovascular disease in patients with rheumatoid arthritis: a cohort study (2011) (42)
- Lack of echocardiographic and Doppler abnormalities in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. (2006) (41)
- Influence of the IL6 Gene in Susceptibility to Systemic Sclerosis (2012) (40)
- An Audit of the Variability of Diagnosis and Management of Gout in the Rheumatology Setting: The Gout Evaluation and Management Study (2011) (40)
- Cancer in biopsy-proven giant cell arteritis. A population-based study. (2007) (39)
- Expression of osteoprotegerin and its ligands, RANKL and TRAIL, in rheumatoid arthritis (2016) (39)
- Interleukin 12 (IL12B), interleukin 12 receptor (IL12RB1) and interleukin 23 (IL23A) gene polymorphism in systemic lupus erythematosus. (2005) (39)
- IgA Vasculitis: Genetics and Clinical and Therapeutic Management (2018) (39)
- Genetic Markers of Cardiovascular Disease in Rheumatoid Arthritis (2012) (39)
- Single-organ cutaneous small-vessel vasculitis according to the 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides: a study of 60 patients from a series of 766 cutaneous vasculitis cases. (2015) (38)
- Increased prevalence of subclinical atherosclerosis in patients with hidradenitis suppurativa (HS). (2016) (38)
- A multicenter study confirms CD226 gene association with systemic sclerosis-related pulmonary fibrosis (2012) (38)
- Influence of the IL17A locus in giant cell arteritis susceptibility (2014) (37)
- Endothelial dysfunction in rheumatoid arthritis: influence of HLA-DRB1 alleles. (2004) (37)
- Influence of nitric oxide synthase gene polymorphisms on the risk of cardiovascular events in rheumatoid arthritis. (2009) (37)
- Assessment of cardiovascular risk in rheumatoid arthritis: impact of the new EULAR recommendations on the score cardiovascular risk index (2011) (37)
- HDL cholesterol efflux capacity in rheumatoid arthritis patients: contributing factors and relationship with subclinical atherosclerosis (2017) (37)
- HLA and non-HLA genes in Behçet’s disease: a multicentric study in the Spanish population (2013) (37)
- Implications of upper respiratory tract infections and drugs in the clinical spectrum of Henoch-Schönlein purpura in children. (2004) (37)
- Independent Relationship of Osteoprotegerin Concentrations with Endothelial Activation and Carotid Atherosclerosis in Patients with Severe Rheumatoid Arthritis (2014) (36)
- Clinical approach to cutaneous vasculitis (2005) (36)
- Nailfold Capillaroscopy Characteristics of Antisynthetase Syndrome and Possible Clinical Associations: Results of a Multicenter International Study (2018) (36)
- Clinical association between Kikuchi׳s disease and systemic lupus erythematosus: A systematic literature review. (2017) (36)
- Adipokines, Biomarkers of Endothelial Activation, and Metabolic Syndrome in Patients with Ankylosing Spondylitis (2014) (36)
- Efficacy of Anti-IL6-Receptor Tocilizumab in Refractory Cystoid Macular Edema of Birdshot Retinochoroidopathy Report of Two Cases and Literature Review (2017) (36)
- The novel adipokine progranulin counteracts IL-1 and TLR4-driven inflammatory response in human and murine chondrocytes via TNFR1 (2016) (36)
- Audiovestibular Manifestations in Patients With Ankylosing Spondylitis (2011) (36)
- Rapid beneficial effect of the IL-6 receptor blockade on insulin resistance and insulin sensitivity in non-diabetic patients with rheumatoid arthritis. (2019) (36)
- Deletion of the late cornified envelope genes, LCE3C and LCE3B, is associated with rheumatoid arthritis. (2010) (36)
- Inducible nitric oxide synthase polymorphism is associated with susceptibility to Henoch-Schönlein purpura in northwestern Spain. (2005) (35)
- Implication of IL-2/IL-21 region in systemic sclerosis genetic susceptibility (2012) (35)
- Association of CD24 gene polymorphisms with susceptibility to biopsy-proven giant cell arteritis. (2008) (35)
- Carotid ultrasound in the cardiovascular risk stratification of patients with rheumatoid arthritis: when and for whom? (2012) (35)
- COVID‐19 patients with psoriasis and psoriatic arthritis on biologic immunosuppressant therapy vs apremilast in North Spain (2020) (35)
- The interleukin 23 receptor gene does not confer risk to systemic sclerosis and is not associated with systemic sclerosis disease phenotype (2008) (35)
- Anti-citrullinated peptide antibodies and their value for predicting responses to biologic agents: a review (2016) (35)
- Benign Paroxysmal Positional Vertigo and Clinical Test of Sensory Interaction and Balance in Systemic Sclerosis (2008) (34)
- Association Between Toll-like Receptor 4 Gene Polymorphism and Biopsy-proven Giant Cell Arteritis (2009) (34)
- Endothelial nitric oxide synthase haplotype associations in biopsy-proven giant cell arteritis. (2003) (34)
- Ear, Nose and Throat Manifestations of Wegener's Granulomatosis (Granulomatosis With Polyangiitis) (2012) (34)
- Carotid artery plaque in women with rheumatoid arthritis and low estimated cardiovascular disease risk: a cross-sectional study (2015) (34)
- Vitamin D deficiency in chronic inflammatory rheumatic diseases: results of the cardiovascular in rheumatology [CARMA] study (2015) (34)
- Lipoprotein(a) concentrations in rheumatoid arthritis on biologic therapy: Results from the CARdiovascular in rheuMAtology study project. (2017) (33)
- Influence of the STAT3 genetic variants in the susceptibility to psoriatic arthritis and Behcet's disease. (2013) (33)
- Clinical spectrum time course of interstitial pneumonia with autoimmune features in patients positive for antisynthetase antibodies. (2017) (33)
- Urticarial Vasculitis in Northern Spain (2014) (33)
- Association between HLA-DRB1*15 and secondary Sjögren's syndrome in patients with rheumatoid arthritis. (2000) (33)
- Lack of association between ankylosing spondylitis and a functional polymorphism of PTPN22 proposed as a general susceptibility marker for autoimmunity (2005) (32)
- IL-6: linking chronic inflammation and vascular calcification (2019) (32)
- Systemic and cerebral endothelial dysfunction in chronic migraine. A case-control study with an active comparator (2016) (32)
- Association of HLA-B*41:02 with Henoch-Schönlein Purpura (IgA Vasculitis) in Spanish individuals irrespective of the HLA-DRB1 status (2015) (32)
- The ZC3HC1 rs11556924 polymorphism is associated with increased carotid intima-media thickness in patients with rheumatoid arthritis (2013) (32)
- Sex differences in patients with systemic lupus erythematosus from Northwest Spain (2013) (31)
- Marked Independent Relationship between Circulating Interleukin-6 Concentrations and Endothelial Activation in Rheumatoid Arthritis (2013) (31)
- High triglycerides and low high-density lipoprotein cholesterol lipid profile in rheumatoid arthritis: A potential link among inflammation, oxidative status, and dysfunctional high-density lipoprotein. (2017) (31)
- Insulin resistance in systemic lupus erythematosus patients: contributing factors and relationship with subclinical atherosclerosis. (2017) (31)
- Investigation of TLR5 and TLR7 as candidate genes for susceptibility to systemic lupus erythematosus. (2009) (31)
- HLA-DRB1 association with Henoch-Schonlein purpura. (2014) (31)
- Influence of interleukin 10 promoter polymorphisms in susceptibility to giant cell arteritis in Northwestern Spain. (2007) (31)
- Drug-associated Cutaneous Vasculitis: Study of 239 Patients from a Single Referral Center (2014) (31)
- Epistatic Interaction of ERAP1 and HLA-B in Behçet Disease: A Replication Study in the Spanish Population (2014) (31)
- Decreased expression of methylene tetrahydrofolate reductase (MTHFR) gene in patients with rheumatoid arthritis. (2016) (30)
- Atherosclerotic disease in axial spondyloarthritis: increased frequency of carotid plaques. (2015) (30)
- Austrian syndrome: report of two new cases and literature review. (2006) (30)
- Cardiovascular disease in rheumatoid arthritis. (2006) (30)
- Sensitivity and Specificity of the CASPAR Criteria for Psoriatic Arthritis in a Family Medicine Clinic Setting (2008) (29)
- CARD8 rs2043211 (p.C10X) polymorphism is not associated with disease susceptibility or cardiovascular events in Spanish rheumatoid arthritis patients. (2013) (29)
- Osteoprotegerin Concentrations Relate Independently to Established Cardiovascular Disease in Rheumatoid Arthritis (2015) (29)
- Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring in clinical practice: the spanish cohort of the COMORA study. (2017) (29)
- Association of a functional inducible nitric oxide synthase promoter variant with susceptibility to biopsy-proven giant cell arteritis. (2005) (29)
- Adipokines induce pro‐inflammatory factors in activated Cd4+ T cells from osteoarthritis patient (2017) (28)
- Persistent chronic inflammation contributes to the development of cancer in patients with rheumatoid arthritis from a defined population of northwestern Spain. (2007) (28)
- Efficacy and safety of abatacept in interstitial lung disease of rheumatoid arthritis: A systematic literature review. (2021) (28)
- Cross‐disease Meta‐analysis of Genome‐wide Association Studies for Systemic Sclerosis and Rheumatoid Arthritis Reveals IRF4 as a New Common Susceptibility Locus (2016) (28)
- Tocilizumab for the treatment of adult-onset Still’s disease (2019) (28)
- Impaired HDL cholesterol efflux capacity in systemic lupus erythematosus patients is related to subclinical carotid atherosclerosis. (2020) (28)
- SLC22A4, RUNX1, and SUMO4 polymorphisms are not associated with rheumatoid arthritis: a case-control study in a Spanish population. (2006) (27)
- Paraoxonase 1 Activity Is Modulated by the rs662 Polymorphism and IgG Anti–High‐Density Lipoprotein Antibodies in Patients With Rheumatoid Arthritis: Potential Implications for Cardiovascular Disease (2016) (27)
- Bone mass and vitamin D in patients with systemic sclerosis from two Spanish regions. (2012) (27)
- Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross‐Disease Meta‐Analysis of Genome‐Wide Association Studies (2016) (27)
- Early large vessel systemic vasculitis in adults. (2019) (27)
- Evidence of New Risk Genetic Factor to Systemic Lupus Erythematosus: The UBASH3A Gene (2013) (26)
- Golimumab in refractory uveitis associated to juvenile idiopathic arthritis: multicentre study of 7 cases and literature review. (2018) (26)
- Identification of novel genetic markers associated with the clinical phenotypes of systemic sclerosis through a genome wide association strategy (2010) (26)
- Infective endocarditis due to Streptococcus bovis in a series of nonaddict patients: clinical and morphological characteristics of 20 cases and review of the literature. (2003) (26)
- Lack of Association between ABO, PPAP2B, ADAMST7, PIK3CG, and EDNRA and Carotid Intima-Media Thickness, Carotid Plaques, and Cardiovascular Disease in Patients with Rheumatoid Arthritis (2014) (26)
- Association between IL-18 gene polymorphisms and biopsy-proven giant cell arteritis (2010) (26)
- Lack of association between intercellular adhesion molecule-1 gene polymorphisms and giant cell arteritis. (2001) (25)
- Antisynthetase syndrome or what else? Different perspectives indicate the need for new classification criteria (2017) (25)
- Lack of association of a functional single nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with susceptibility to biopsy-proven giant cell arteritis. (2005) (25)
- Analysis of vascular endothelial growth factor (VEGF) functional variants in rheumatoid arthritis. (2005) (25)
- Epistatic Interaction between BANK1 and BLK in Rheumatoid Arthritis: Results from a Large Trans-Ethnic Meta-Analysis (2013) (25)
- Influence of MHCIITA rs3087456 and rs4774 polymorphisms in the susceptibility to cardiovascular disease of patients with rheumatoid arthritis. (2012) (25)
- Lack of association of PTPN22, STAT4 and TRAF1/C5 gene polymorphisms with cardiovascular risk in rheumatoid arthritis. (2010) (25)
- Localized vasculitis of the gastrointestinal tract: a case report and literature review. (2008) (24)
- Lack of association between ADIPOQ rs266729 and ADIPOQ rs1501299 polymorphisms and cardiovascular disease in rheumatoid arthritis patients. (2011) (24)
- Protective Role of the Interleukin 33 rs3939286 Gene Polymorphism in the Development of Subclinical Atherosclerosis in Rheumatoid Arthritis Patients (2015) (24)
- Lack of association between macrophage migration inhibitory factor-173 gene polymorphism with disease susceptibility and cardiovascular risk in rheumatoid arthritis patients from northwestern Spain. (2010) (24)
- Impaired beta cell function is present in nondiabetic rheumatoid arthritis patients (2013) (24)
- Corticotropin releasing hormone promoter polymorphisms in giant cell arteritis and polymyalgia rheumatica. (2002) (24)
- Giant cell arteritis: is the clinical spectrum of the disease changing? (2019) (24)
- Cross-phenotype analysis of Immunochip data identifies KDM4C as a relevant locus for the development of systemic vasculitis (2018) (24)
- Anakinra for the treatment of adult-onset Still’s disease (2018) (23)
- Impact of Comorbidity on Physical Function in Patients With Ankylosing Spondylitis and Psoriatic Arthritis Attending Rheumatology Clinics: Results From a Cross‐Sectional Study (2020) (23)
- Cardiovascular risk stratification in axial spondyloarthritis: carotid ultrasound is more sensitive than coronary artery calcification score to detect high-cardiovascular risk axial spondyloarthritis patients. (2018) (23)
- Efficacy of a multidisciplinary treatment program in patients with severe fibromyalgia (2012) (23)
- Association of a non-synonymous functional variant of the ITGAM gene with systemic sclerosis (2011) (23)
- Adiponectin and resistin serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy. (2013) (23)
- Carotid ultrasound in the cardiovascular risk stratification of patients with ankylosing spondylitis: results of a population-based study. (2016) (23)
- Vascular endothelial growth factor A and cardiovascular disease in rheumatoid arthritis patients. (2011) (23)
- Evidence of association of the NLRP1 gene with giant cell arteritis (2012) (23)
- Golimumab in uveitis previously treated with other anti-TNF-alpha drugs: a retrospective study of three cases from a single centre and literature review. (2014) (23)
- Serum Levels of Anti-PON1 and Anti-HDL Antibodies as Potential Biomarkers of Premature Atherosclerosis in Systemic Lupus Erythematosus (2017) (23)
- Carotid plaques as predictors of cardiovascular events in patients with Rheumatoid Arthritis. Results from a 5-year-prospective follow-up study. (2020) (22)
- Biologic therapy in severe and refractory peripheral ulcerative keratitis (PUK). Multicenter study of 34 patients. (2020) (22)
- Short-term effect of anti-TNF-alpha therapy on nitric oxide production in patients with severe rheumatoid arthritis. (2009) (22)
- Successful effect of tocilizumab in anti-TNF-α-induced palmoplantar pustulosis in rheumatoid arthritis. (2012) (22)
- Evidence for PTPN22 R620W Polymorphism As the Sole Common Risk Variant for Rheumatoid Arthritis in the 1p13.2 Region (2011) (22)
- Inflammation, endothelial function and atherosclerosis in rheumatoid arthritis (2012) (22)
- Association of acid phosphatase locus 1*C allele with the risk of cardiovascular events in rheumatoid arthritis patients (2011) (22)
- Study of six X-linked tetranucleotide microsatellites: population data from five Spanish regions (2006) (22)
- Rheumatoid arthritis: Obesity impairs efficacy of anti-TNF therapy in patients with RA (2012) (22)
- Lack of association between LEP rs2167270 (19 G>A) polymorphism and disease susceptibility and cardiovascular disease in patients with rheumatoid arthritis. (2011) (21)
- Leptin and visfatin serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy. (2013) (21)
- Osteoprotegerin correlates with disease activity and endothelial activation in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy. (2014) (21)
- Interferon regulatory factor 5 genetic variants are associated with cardiovascular disease in patients with rheumatoid arthritis (2014) (21)
- Cholesteryl Ester Transfer Protein in Patients with Rheumatoid Arthritis (2013) (21)
- No primary association of MICA polymorphism with systemic lupus erythematosus. (2006) (21)
- Lack of association between IL6 single nucleotide polymorphisms and cardiovascular disease in Spanish patients with rheumatoid arthritis. (2011) (21)
- Tocilizumab: from the rheumatology practice to the fight against COVID-19, a virus infection with multiple faces (2020) (21)
- Lack of association between TLR4 rs4986790 polymorphism and risk of cardiovascular disease in patients with rheumatoid arthritis. (2012) (20)
- Human leukocyte antigen-DQB1 and -DRB1 associations in patients with idiopathic sudden sensorineural hearing loss from a defined population of Northwest Spain (2005) (20)
- Smoking cessation is associated with lower disease activity and predicts cardiovascular risk reduction in rheumatoid arthritis patients (2019) (20)
- Identification of the oxidative stress-related gene MSRA as a rheumatoid arthritis susceptibility locus by genome-wide pathway analysis. (2010) (20)
- The Framingham Score and the Systematic Coronary Risk Evaluation at Low Cutoff Values Are Useful Surrogate Markers of High-risk Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis (2016) (20)
- Anti-TNF-α therapy reduces endothelial cell activation in non-diabetic ankylosing spondylitis patients (2015) (20)
- Investigations into Audiovestibular Manifestations in Patients with Psoriatic Arthritis (2014) (19)
- GIMAP and Behçet disease: no association in the European population (2014) (19)
- Analysis of the REL polymorphism rs13031237 in autoimmune diseases (2010) (19)
- The Spectrum of Interstitial Lung Disease Associated with Autoimmune Diseases: Data of a 3.6-Year Prospective Study from a Referral Center of Interstitial Lung Disease and Lung Transplantation † (2020) (19)
- Use of positron emission tomography (PET) for the diagnosis of large-vessel vasculitis. (2015) (19)
- Influence of CD40 rs1883832 Polymorphism in Susceptibility to and Clinical Manifestations of Biopsy-proven Giant Cell Arteritis (2010) (19)
- Inflammatory Arthritis and Heart Disease. (2018) (19)
- Current and emerging diagnosis tools and therapeutics for giant cell arteritis (2018) (19)
- The Spanish version of the 2010 American College of Rheumatology Preliminary Diagnostic Criteria for fibromyalgia: reliability and validity assessment. (2016) (18)
- Influence of elevated-CRP level-related polymorphisms in non-rheumatic Caucasians on the risk of subclinical atherosclerosis and cardiovascular disease in rheumatoid arthritis (2016) (18)
- Tocilizumab for the treatment of rheumatoid arthritis (2012) (18)
- Brief Report: Association of HLA–DRB1*01 With IgA Vasculitis (Henoch‐Schönlein) (2015) (18)
- Role of rs1343151 IL23R and rs3790567 IL12RB2 Polymorphisms in Biopsy-proven Giant Cell Arteritis (2011) (18)
- Lack of association between endothelial nitric oxide synthase polymorphisms and Henoch-Schönlein purpura. (2004) (18)
- Implication of the age in the clinical spectrum of giant cell arteritis. (2008) (18)
- Proprotein convertase subtilisin/kexin type 9 in rheumatoid arthritis. (2016) (18)
- A Candidate Gene Approach Identifies an IL33 Genetic Variant as a Novel Genetic Risk Factor for GCA (2014) (18)
- Evidence for uncoupling of clinical and 18-FDG activity of PET/CT scan improvement in tocilizumab-treated patients with large-vessel giant cell arteritis. (2020) (17)
- CD4+CD25+ T Cell-Dependent Inhibition of Autoimmunity in Transgenic Mice Overexpressing Human Bcl-2 in T Lymphocytes1 (2007) (17)
- Standardization procedure for flow cytometry data harmonization in prospective multicenter studies (2020) (17)
- Tocilizumab in giant cell arteritis: differences between the GiACTA trial and a multicentre series of patients from the clinical practice. (2020) (17)
- Study of a functional polymorphism in thep53 gene in systemic lupus erythematosus: lack of replication in a Spanish population (2006) (16)
- Lack of association between hypoxia inducible factor-1 alpha gene polymorphisms and biopsy-proven giant cell arteritis. (2010) (16)
- Polymorphism of the MHC class II Eb gene determines the protection against collagen-induced arthritis (1995) (16)
- Antibodies to paraoxonase 1 are associated with oxidant status and endothelial activation in rheumatoid arthritis. (2016) (16)
- Henoch-Schönlein purpura (IgA vasculitis): the paradox of the different incidence and clinical spectrum in children and adults. (2017) (16)
- Controversies on the use of corticosteroid therapy in children with Henoch-Schönlein purpura. (2005) (16)
- Brief Report: Lack of Replication of an Association Between Anti–Citrullinated Fibrinogen and Subclinical Atherosclerosis in Patients With Rheumatoid Arthritis (2015) (16)
- Identification of a 3′‐Untranslated Genetic Variant of RARB Associated With Carotid Intima‐Media Thickness in Rheumatoid Arthritis: A Genome‐Wide Association Study (2019) (16)
- Oral Calcidiol Is More Effective Than Cholecalciferol Supplementation to Reach Adequate 25(OH)D Levels in Patients with Autoimmune Diseases Chronically Treated with Low Doses of Glucocorticoids: A “Real-Life” Study (2015) (16)
- Role of the rs6822844 gene polymorphism at the IL2-IL21 region in biopsy-proven giant cell arteritis. (2011) (16)
- New insights into the pathogenesis of giant cell arteritis and hopes for the clinic (2016) (16)
- Relationship of abdominal adiposity and body composition with endothelial dysfunction in patients with rheumatoid arthritis. (2015) (16)
- Lack of association of IL6R rs2228145 and IL6ST/gp130 rs2228044 gene polymorphisms with cardiovascular disease in patients with rheumatoid arthritis. (2011) (16)
- Cutaneous vasculitis: a diagnostic approach. (2003) (16)
- Association of CD247 Polymorphisms with Rheumatoid Arthritis: A Replication Study and a Meta-Analysis (2013) (16)
- Rheumatoid arthritis: genetic variants as biomarkers of cardiovascular disease. (2014) (15)
- Lack of association of NAMPT rs9770242 and rs59744560 polymorphisms with disease susceptibility and cardiovascular risk in patients with rheumatoid arthritis. (2011) (15)
- TNF +489 polymorphism does not contribute to susceptibility to rheumatoid arthritis. (2002) (15)
- Asymmetric dimethylarginine serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy. (2013) (15)
- Kidney Function, Endothelial Activation and Atherosclerosis in Black and White Africans with Rheumatoid Arthritis (2015) (15)
- Giant cell arteritis: more than a cranial disease. (2020) (15)
- Lack of association of a functional -94ins/delATTG NFKB1 promoter polymorphism with susceptibility and clinical expression of biopsy-proven giant cell arteritis in northwest Spain. (2006) (15)
- Analysis of Ancestral and Functionally Relevant CD5 Variants in Systemic Lupus Erythematosus Patients (2014) (15)
- Study of the role of functional variants of SLC22A4, RUNX1 and SUMO4 in systemic lupus erythematosus (2005) (15)
- Cardiovascular risk assessment according to a national calibrated score risk index in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. (2014) (15)
- An Update on the Role of Leptin in the Immuno-Metabolism of Cartilage (2021) (15)
- Giant left atrial myxoma mimicking severe mitral valve stenosis. (2008) (15)
- Refractory polymyalgia rheumatica as presenting manifestation of large-vessel vasculitis associated to sarcoidosis. Successful response to adalimumab. (2012) (14)
- Cutaneous Vasculitis: A Rheumatologist Perspective (2013) (14)
- Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosis. (2015) (14)
- A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease (2020) (14)
- NPSR1 Gene Is Associated with Reduced Risk of Rheumatoid Arthritis (2012) (14)
- Medical management of polymyalgia rheumatica (2010) (14)
- Interleukin 1 beta (IL1ß) rs16944 genetic variant as a genetic marker of severe renal manifestations and renal sequelae in Henoch-Schönlein purpura. (2016) (14)
- Replication of association of the interleukin 23 receptor rs1343151 variant with rheumatoid arthritis in Caucasian sample sets (2011) (14)
- Henoch-Schönlein purpura and cutaneous leukocytoclastic angiitis exhibit different HLA-DRB1 associations. (2002) (14)
- The increased risk of ventricular diastolic dysfunction and congestive heart failure in patients with rheumatoid arthritis is independent of the duration of the disease. (2005) (14)
- [Audiovestibular manifestations in systemic vasculitis]. (2009) (14)
- Corticoids synergize with IL-1 in the induction of LCN2. (2017) (14)
- Lack of association between macrophage migration inhibitory factor gene (-173 G/C) polymorphism and cutaneous vasculitis. (2006) (14)
- Atherosclerosis in Rheumatoid Arthritis (2012) (14)
- Influence of coronary artery disease and subclinical atherosclerosis related polymorphisms on the risk of atherosclerosis in rheumatoid arthritis (2017) (13)
- Relationship between endothelial dysfunction and osteoprotegerin, vitamin D, and bone mineral density in patients with rheumatoid arthritis. (2015) (13)
- Lack of Association Between TRAF1/C5 Gene Polymorphisms and Biopsy-proven Giant Cell Arteritis (2010) (13)
- SMAD3 rs17228212 Gene Polymorphism Is Associated with Reduced Risk to Cerebrovascular Accidents and Subclinical Atherosclerosis in Anti-CCP Negative Spanish Rheumatoid Arthritis Patients (2013) (13)
- Two Polymorphisms in the Epithelial Cell-Derived Neutrophil-Activating Peptide (ENA-78) Gene (2005) (13)
- Genetic risk scores and number of autoantibodies in patients with rheumatoid arthritis (2013) (13)
- Biologic therapy in ANCA-negative vasculitis. (2015) (13)
- New Criteria Needed for Antisynthetase Syndrome. (2017) (13)
- Polymyalgia rheumatica as presenting manifestation of vasculitis involving the lower extremities in a patient with ulcerative colitis. (2012) (13)
- Association study of MIA3 rs17465637 polymorphism with cardiovascular disease in rheumatoid arthritis patients. (2012) (13)
- Psoriasis: a skin disease associated with increased cardiovascular risk. (2012) (13)
- Association of circulating calprotectin with lipid profile in axial spondyloarthritis (2018) (13)
- Multiple parosteal lipoma associated to polyarthritis. (2006) (13)
- Association of Trabecular Bone Score with Inflammation and Adiposity in Patients with Psoriasis: Effect of Adalimumab Therapy (2016) (13)
- Levels of the Novel Endogenous Antagonist of Ghrelin Receptor, Liver-Enriched Antimicrobial Peptide-2, in Patients with Rheumatoid Arthritis (2020) (13)
- Functional capacity in rheumatoid arthritis patients: comparison between Spanish and Brazilian sample (2011) (13)
- Analysis of the Interferon Gamma (rs2430561, +874T/A) Functional Gene Variant in Relation to the Presence of Cardiovascular Events in Rheumatoid Arthritis (2012) (13)
- Antitumour necrosis factor α treatment reduces retinol-binding protein 4 serum levels in non-diabetic ankylosing spondylitis patients (2013) (13)
- MCP-1 gene haplotype association in biopsy proven giant cell arteritis. (2005) (13)
- Lack of association between IL-1 cluster and TNF-alpha gene polymorphisms and giant cell arteritis. (2002) (12)
- Sex and Cardiovascular Involvement in Inflammatory Joint Diseases (2019) (12)
- Treatment of giant cell arteritis. (2019) (12)
- Incretins in patients with rheumatoid arthritis (2017) (12)
- Cardiovascular mortality and cardiovascular event rates in patients with inflammatory rheumatic diseases in the CARdiovascular in rheuMAtology (CARMA) prospective study-results at 5 years of follow-up. (2020) (12)
- Protein tyrosine phosphatase non-receptor 22 and C-Src tyrosine kinase genes are down-regulated in patients with rheumatoid arthritis (2017) (12)
- Molecular screening and association study of IL15 gene polymorphisms in rheumatoid arthritis. (2007) (12)
- Role of the CCR5/Δ32CCR5 polymorphism in biopsy-proven giant cell arteritis. (2011) (12)
- Disease Damage Influences Cardiovascular Risk Reclassification Based on Carotid Ultrasound in Patients with Systemic Lupus Erythematosus (2019) (12)
- The lp13.3 genomic region -rs599839- is associated with endothelial dysfunction in patients with rheumatoid arthritis (2012) (12)
- Functional Variants of Fc Gamma Receptor (FCGR2A) and FCGR3A Are Not Associated with Susceptibility to Systemic Sclerosis in a Large European Study (EUSTAR) (2010) (12)
- Retinol-binding Protein 4 in Rheumatoid Arthritis-related Insulin Resistance and β-cell Function (2014) (12)
- Significant sE-Selectin levels reduction after 6 months of anti-TNF-α therapy in non-diabetic patients with moderate-to-severe psoriasis (2017) (12)
- Disease Activity Influences Cardiovascular Risk Reclassification Based on Carotid Ultrasound in Patients with Psoriatic Arthritis (2019) (12)
- BioLogic THERAPY IN COVID-19 (2020) (12)
- Giant cell arteritis in Mediterranean countries: comment on the article by Salvarani et al. (1992) (12)
- Asymmetric dimethylarginine but not osteoprotegerin correlates with disease severity in patients with moderate‐to‐severe psoriasis undergoing anti‐tumor necrosis factor‐α therapy (2016) (12)
- IL-18 gene polymorphisms in Henoch-Schönlein purpura. (2010) (12)
- Omentin: a biomarker of cardiovascular risk in individuals with axial spondyloarthritis (2020) (12)
- Association of a rare variant of the TNFSF13B gene with susceptibility to Rheumatoid Arthritis and Systemic Lupus Erythematosus (2018) (12)
- Reclassification into very-high cardiovascular risk after carotid ultrasound in patients with axial spondyloarthritis. (2020) (12)
- Rituximab in the Treatment of Interstitial Lung Disease Associated with Autoimmune Diseases: Experience from a Single Referral Center and Literature Review (2020) (11)
- Subclinical atherosclerosis in patients with psoriatic arthritis. (2008) (11)
- C-Reactive Protein Gene Polymorphisms in Biopsy-proven Giant Cell Arteritis from Northwestern Spain (2008) (11)
- Novel association of acid phosphatase locus 1*C allele with systemic lupus erythematosus. (2012) (11)
- Lack of association between interleukin-6 promoter polymorphism at position -174 and Henoch-Schönlein purpura (2007) (11)
- Apelin serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy. (2013) (11)
- Diabetes mellitus and cardiovascular risk management in patients with rheumatoid arthritis: an international audit (2021) (11)
- Antitumour necrosis factor-α therapy modulates angiopoietin-2 serum levels in non-diabetic ankylosing spondylitis patients (2013) (11)
- Long-term Follow-up and Optimization of Infliximab in Refractory Uveitis Due to Behçet Disease: National Study of 103 White Patients (2020) (11)
- Circulating levels of adiponectin, leptin, resistin and visfatin in non-diabetics patients with hidradenitis suppurativa (2019) (11)
- E-selectin polymorphism in erythema nodosum secondary to sarcoidosis. (2004) (11)
- Generalized granuloma annulare and giant cell arteritis. (2008) (11)
- Endothelial Progenitor Cells as a Potential Biomarker in Interstitial Lung Disease Associated with Rheumatoid Arthritis (2020) (11)
- Subclinical atherosclerotic disease in ankylosing spondylitis and non-radiographic axial spondyloarthritis. A multicenter study on 806 patients. (2021) (11)
- Vitamin D receptor GATG haplotype association with atherosclerotic disease in patients with rheumatoid arthritis. (2016) (11)
- Lack of association between toll-like receptor 4 gene polymorphism and Henoch-Schönlein purpura. (2010) (11)
- Glucocorticoid-related cardiovascular and cerebrovascular events in rheumatic diseases: myth or reality? (2007) (11)
- Role of PTPN22 and CSK gene polymorphisms as predictors of susceptibility and clinical heterogeneity in patients with Henoch-Schönlein purpura (IgA vasculitis) (2015) (11)
- Unmet needs in the management of cardiovascular risk in inflammatory joint diseases (2019) (11)
- Isolated pulmonary vasculitis: case report and literature review. (2015) (11)
- The 11q23.3 genomic region-rs964184-is associated with cardiovascular disease in patients with rheumatoid arthritis. (2013) (11)
- Pacemaker infection due to Aspergillus: report of two cases and literature review (2005) (11)
- Lack of association between macrophage migration inhibitory factor gene polymorphism and giant cell arteritis. (2005) (11)
- Analysis of the association between CD40 and CD40 ligand polymorphisms and systemic sclerosis (2012) (11)
- Role of the C8orf13-BLK region in biopsy-proven giant cell arteritis. (2010) (11)
- Investigation of a PON1 gene polymorphism (rs662 polymorphism) as predictor of subclinical atherosclerosis in patients with rheumatoid arthritis (2014) (11)
- Lack of association between altitude and incidence of giant cell arteritis in Northwest Spain. (2004) (11)
- Inflammation: NSAIDs and cardiovascular risk in arthritis (2017) (10)
- Disease activity influences the reclassification of rheumatoid arthritis into very high cardiovascular risk (2021) (10)
- Combined use of QRISK3 and SCORE as predictors of carotid plaques in patients with rheumatoid arthritis. (2020) (10)
- KCNA5 gene is not confirmed as a systemic sclerosis-related pulmonary arterial hypertension genetic susceptibility factor (2012) (10)
- Osteoprotegerin CGA Haplotype Protection against Cerebrovascular Complications in Anti-CCP Negative Patients with Rheumatoid Arthritis (2014) (10)
- Benign Paroxysmal Positional Vertigo and Clinical Test of Sensory Interaction and Balance in Ankylosing Spondylitis (2011) (10)
- Rheumatoid arthritis and accelerated atherogenesis. (2004) (10)
- CXCL5 Gene Polymorphism Association with Diabetes Mellitus (2012) (10)
- Leptin in Osteoarthritis and Rheumatoid Arthritis: Player or Bystander? (2022) (10)
- Differences in Capacity of High‐Density Lipoprotein Cholesterol Efflux Between Patients With Systemic Lupus Erythematosus and Rheumatoid Arthritis (2020) (10)
- Influence of MUC5B gene on antisynthetase syndrome (2020) (10)
- Identification of streptococcal proteins reacting with sera from Behçet's disease and rheumatic disorders (2010) (9)
- Proprotein convertase subtilisin/kexin type 9 is related to disease activity and damage in patients with systemic erythematosus lupus (2020) (9)
- Serum cathepsin S and cystatin C: relationship to subclinical carotid atherosclerosis in rheumatoid arthritis. (2016) (9)
- Interleukin-6 receptor blockade or TNFα inhibition for reducing glycaemia in patients with RA and diabetes: post hoc analyses of three randomised, controlled trials (2020) (9)
- Optic neuritis following treatment with isoniazid in a hemodialyzed patient. (1993) (9)
- Carotid intima-media thickness and endothelial function: useful surrogate markers for establishing cardiovascular risk in patients with inflammatory rheumatic disease (2008) (9)
- Patients with Ankylosing Spondylitis and Low Disease Activity because of Anti-TNF-Alpha Therapy Have Higher TRAIL Levels Than Controls: A Potential Compensatory Effect (2014) (9)
- Cardiovascular risk factor assessment: still an unmet need in chronic inflammatory diseases (2016) (9)
- Audiovestibular manifestations in systemic vasculitis (2009) (9)
- Lack of association between A561C E-selectin polymorphism and large and small-sized blood vessel vasculitides. (2002) (9)
- TNF-related apoptosis-inducing ligand and cardiovascular disease in rheumatoid arthritis. (2015) (9)
- A rare polymorphism in Toll Like Receptor 2 is associated with systemic sclerosis phenotype and increases production of inflammatory mediators (2011) (9)
- Relationship Between Insulin Sensitivity and β-Cell Secretion in Nondiabetic Subjects with Rheumatoid Arthritis (2018) (9)
- Applicability of the 2006 European League Against Rheumatism (EULAR) criteria for the classification of Henoch-Schönlein purpura. An analysis based on 766 patients with cutaneous vasculitis. (2015) (9)
- Correlation between insulin resistance and serum ghrelin in non-diabetic ankylosing spondylitis patients undergoing anti-TNF-α therapy. (2013) (9)
- Gene polymorphisms and therapy in rheumatoid arthritis (2016) (9)
- Otorhinolaryngological manifestations in patients with Behçet disease (2014) (9)
- Hyperlipoprotein(a) in patients with spondyloarthritis: results of the Cardiovascular in Rheumatology (CARMA) project. (2019) (8)
- Drug therapies for polymyalgia rheumatica: a pharmacotherapeutic update (2018) (8)
- Interleukin 12 ( IL 12 B ) , interleukin 12 receptor ( IL 12 RB 1 ) and interleukin 23 ( IL 23 A ) gene polymorphism in systemic lupus erythematosus (2005) (8)
- The role of biologics in the treatment of giant cell arteritis (2018) (8)
- Oculographic, Clinical Test of Sensory Integration and Balance and Computerized Dynamic Posturography Findings in Patients With Psoriatic Arthritis. (2017) (8)
- Points to consider in cardiovascular disease risk management among patients with rheumatoid arthritis living in South Africa, an unequal middle income country (2020) (8)
- Incidence of first cardiovascular event in Spanish patients with inflammatory rheumatic diseases: prospective data from the CARMA project. (2019) (8)
- Anti-IL-6 therapy reduces leptin serum levels in patients with rheumatoid arthritis. (2020) (8)
- ABATACEPT IN MONOTHERAPY VERSUS COMBINED IN INTERSTITIAL LUNG DISEASE OF RHEUMATOID ARTHRITIS. MULTICENTER STUDY OF 263 CAUCASIAN PATIENTS. (2021) (8)
- Prediction of cardiovascular events in rheumatoid arthritis using risk age calculations: evaluation of concordance across risk age models (2020) (8)
- Apremilast in refractory orogenital ulcers and other manifestations of Behçet's disease. A national multicentre study of 51 cases in clinical practice. (2020) (8)
- Role of the rs 6822844 gene polymorphism at the IL 2-IL 21 region in biopsy-proven giant cell arteritis (2006) (8)
- Tocilizumab in refractory giant cell arteritis. Monotherapy versus combined therapy with conventional immunosuppressive drugs. Observational multicenter study of 134 patients. (2021) (8)
- Treatment of polymyalgia rheumatica. (2019) (8)
- Cranial and extracranial giant cell arteritis share similar HLA-DRB1 association. (2020) (8)
- Pollutants make rheumatic diseases worse: Facts on polychlorinated biphenyls (PCBs) exposure and rheumatic diseases. (2016) (8)
- Use of statins is associated with a lower prevalence of generalised osteoarthritis (2014) (8)
- Polymorphisms in the interleukin 4, interleukin 13 and corresponding receptor genes are not associated with Systemic Sclerosis and do not influence gene expression (2010) (8)
- [Otorhinolaryngological manifestations in patients with Behçet disease]. (2014) (8)
- Pulse wave velocity and augmentation index are not independently associated with carotid atherosclerosis in patients with rheumatoid arthritis (2017) (8)
- Clinical guidelines: Best practices and uncertainties in the management of PMR (2016) (8)
- The presence of both HLA-DRB1[*]04:01 and HLA-B[*]15:01 increases the susceptibility to cranial and extracranial giant cell arteritis. (2021) (7)
- Implication of osteoprotegerin and sclerostin in axial spondyloarthritis cardiovascular disease: study of 163 Spanish patients. (2018) (7)
- Reappraisal of the 1990 American College of Rheumatology criteria for the classification of cutaneous vasculitis: an analysis based on 766 patients. (2014) (7)
- Tocilizumab in Behçet's disease with refractory ocular and/or neurological involvement: response according to different clinical phenotypes. (2021) (7)
- FGF23-Klotho axis in patients with rheumatoid arthritis. (2019) (7)
- Coexistence of Hidradenitis Suppurativa with Autoimmune Thyroiditis: Report of Three Cases (2015) (7)
- [Dyslipidemia in patients with rheumatoid arthritis]. (2016) (7)
- Proprotein convertase subtilisin/kexin type 9 in the dyslipidaemia of patients with axial spondyloarthritis is related to disease activity. (2020) (7)
- IGF-1 and ADMA Levels Are Inversely Correlated in Nondiabetic Ankylosing Spondylitis Patients Undergoing Anti-TNF-Alpha Therapy (2014) (7)
- Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies. (2022) (7)
- HLA association with the susceptibility to anti-synthetase syndrome. (2020) (7)
- Body Mass Index and Disease Activity in Chronic Inflammatory Rheumatic Diseases: Results of the Cardiovascular in Rheumatology (Carma) Project (2020) (7)
- Amylin in the insulin resistance of patients with rheumatoid arthritis. (2018) (7)
- Contribution of HLA-DRB1 shared epitope alleles and chronic inflammation to the increased incidence of cardiovascular disease in rheumatoid arthritis: comment on the article by Farragher et al. (2008) (7)
- Leveraging Genetic Findings for Precision Medicine in Vasculitis (2019) (7)
- Corrigendum: Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus (2011) (7)
- Regulated upon activation normal T-cell expressed and secreted (RANTES) and epithelial cell-derived neutrophil-activating peptide (ENA-78) gene polymorphisms in patients with biopsy-proven erythema nodosum. (2009) (7)
- HLA-DRB 1 association with Henoch-Schonlein purpura (2014) (7)
- Endothelial Progenitor Cells: Relevant Players in the Vasculopathy and Lung Fibrosis Associated with the Presence of Interstitial Lung Disease in Systemic Sclerosis Patients (2021) (7)
- Autoantibodies and biomarkers of endothelial cell activation in atherosclerosis. (2014) (7)
- Lack of association between the CXCL12 rs501120 polymorphism and cardiovascular disease in Spanish patients with rheumatoid arthritis. (2012) (7)
- Interleukin-1 beta gene polymorphism in patients with biopsy-proven erythema nodosum. (2011) (7)
- HLA-B 35 Association with Nephritis in Henoch-Schönlein Purpura (2004) (7)
- Lack of association between RETN rs1862513 polymorphism and cardiovascular disease in rheumatoid arthritis patients. (2011) (7)
- Long-term survival of lung transplantation for interstitial lung disease associated with connective tissue diseases: a study of 26 cases from a referral centre. (2019) (7)
- Carotid Plaque Assessment Reclassifies Patients with Inflammatory Bowel Disease into Very-High Cardiovascular Risk (2021) (6)
- Monomeric C reactive protein (mCRP) regulates inflammatory responses in human and mouse chondrocytes (2021) (6)
- Lack of association between IFNGR 1 gene polymorphisms and biopsy-proven giant cell arteritis (2006) (6)
- Septic discitis as initial manifestation of streptococcus bovis endocarditis. (2006) (6)
- Lack of Association Between STAT4 Gene Polymorphism and Biopsy-proven Giant Cell Arteritis (2009) (6)
- Lack of association between carotid intima-media wall thickness and carotid plaques and markers of endothelial cell activation in rheumatoid arthritis patients undergoing anti-TNF therapy. (2012) (6)
- Immune-related adverse events in patients with solid-organ tumours treated with immunotherapy: a 3-year study of 102 cases from a single centre. (2020) (6)
- Lack of Association between JAK3 Gene Polymorphisms and Cardiovascular Disease in Spanish Patients with Rheumatoid Arthritis (2015) (6)
- Consideration of Antisynthetase Syndrome Features in Classifying Patients as Having Idiopathic Inflammatory Myopathy: Comment on the Article by Lundberg et al (2018) (6)
- Subclinical atherosclerosis is not increased in patients with non-radiographic axial spondyloarthritis. (2016) (6)
- Managing of giant cell arteritis and polymyalgia rheumatica (2016) (6)
- Beta Cell Function is Disrupted in Patients with Systemic Lupus Erythematosus. (2020) (6)
- Identification of a shared genetic risk locus for Kawasaki disease and IgA vasculitis by a cross-phenotype meta-analysis. (2021) (6)
- [Septic arthritis from Streptococcus pneumoniae in rheumatoid arthritis]. (1992) (6)
- Analysis of two autoimmunity genes, IRAK1 and MECP2, in giant cell arteritis. (2014) (6)
- Implication of CXCL5 (epithelial neutrophil-activating peptide 78) in the development of insulin resistance in patients with rheumatoid arthritis. (2018) (6)
- The Number of Traditional Cardiovascular Risk Factors Is Independently Correlated with Disease Activity in Patients with Psoriatic Arthritis (2020) (6)
- Response to 'Infliximab therapy increases body fat mass in early rheumatoid arthritis independently of changes in disease activity and levels of leptin and adiponectin: a randomized study over 21 months' (2011) (6)
- Treating multidrug‐resistant psoriasis with brodalumab, apremilast, methotrexate and prednisone combination therapy in the COVID‐19 pandemic (2020) (5)
- Enhanced Cardiovascular Risk in Rheumatoid Arthritis: Elucidation, Assessment, and Management (2015) (5)
- Evaluation of a Shared Autoimmune Disease-associated Polymorphism of TRAF6 in Systemic Sclerosis and Giant Cell Arteritis (2012) (5)
- Corrigendum: Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy (2017) (5)
- Higher Prevalence and Degree of Insulin Resistance in Patients With Rheumatoid Arthritis Than in Patients With Systemic Lupus Erythematosus (2020) (5)
- HLA–B*08 Identified as the Most Prominently Associated Major Histocompatibility Complex Locus for Anti–Carbamylated Protein Antibody–Positive/Anti–Cyclic Citrullinated Peptide–Negative Rheumatoid Arthritis (2021) (5)
- Lack of association between IL6 gene and Henoch-Schönlein purpura. (2014) (5)
- Genetic Basis of Vasculitides with Neurologic Involvement. (2019) (5)
- Dickkopf-3 (DKK3) Signaling in IL-1α-Challenged Chondrocytes: Involvement of the NF-κB Pathway (2020) (5)
- Moderate and High Disease Activity Predicts the Development of Carotid Plaque in Rheumatoid Arthritis Patients without Classic Cardiovascular Risk Factors: Six Years Follow-Up Study (2021) (5)
- Interleukin-6 promoter polymorphism at position -174 in biopsy-proven patients with erythema nodosum from a defined population. (2008) (5)
- Vaspin in atherosclerotic disease and cardiovascular risk in axial spondyloarthritis: a genetic and serological study (2021) (5)
- A case-control study suggests that the CCR6 locus is not involved in the susceptibility to giant cell arteritis. (2013) (5)
- The search for improvement in the sensitivity of temporal artery biopsy in giant cell arteritis. (2015) (5)
- Toll-like receptor 4 Asp299Gly polymorphism and rheumatoid arthritis: a replicative study in three different populations (2005) (5)
- Potential role of mitral valve strands on stroke recurrence in rheumatoid arthritis. (2003) (5)
- HLA-B*08 identified as the most associated MHC locus for anti-carbamylated protein antibody-positive/anti-CCP-negative rheumatoid arthritis. (2020) (5)
- The influence of inflammation in the development of subclinical atherosclerosis in psoriatic arthritis: comment on ‘Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review’ by Jamnistki et al (2014) (5)
- A Nonsynonymous Functional Variant of the ITGAM Gene Is Not Involved in Biopsy-proven Giant Cell Arteritis (2011) (5)
- Fc receptor gamma subunit polymorphisms and systemic lupus erythematosus. (2004) (5)
- QRISK3 Relation to Carotid Plaque is Higher than that of SCORE In Patients with Systemic Lupus Erythematosus. (2021) (5)
- An international audit of the management of dyslipidaemia and hypertension in patients with rheumatoid arthritis-results from 19 countries. (2021) (5)
- Irisin as a Novel Biomarker of Subclinical Atherosclerosis, Cardiovascular Risk and Severe Disease in Axial Spondyloarthritis (2022) (5)
- Libman-sacks endocarditis and primary antiphospholipid syndrome. (2005) (5)
- Sclerostin serum levels in patients with systemic autoimmune diseases. (2016) (5)
- Telomere length, endothelial activation and carotid atherosclerosis in black and white African patients with rheumatoid arthritis. (2016) (4)
- Endothelial nitric oxide synthase polymorphisms in biopsy-proven erythema nodosum from a defined population. (2007) (4)
- Systemic vasculitides. (2002) (4)
- Evaluation of serum omentin-1 and apelin concentrations in patients with hidradenitis suppurativa (2021) (4)
- Key Molecules of Triglycerides Pathway Metabolism Are Disturbed in Patients With Systemic Lupus Erythematosus (2022) (4)
- Lack of association of epithelial cell-derived neurophil-activating peptide (ENA)-78 gene polymorphism with susceptibility to biopsy-proven giant cell arteritis. (2007) (4)
- The pros and cons of intravenous immunoglobulin treatment in autoimmune nephropathy. (2004) (4)
- Rheumatoid arthritis and anti-TNF-α therapy (2005) (4)
- Autoimmune disease-associated CD226 gene variants are not involved in giant cell arteritis susceptibility in the Spanish population. (2012) (4)
- Interleukin 1 receptor antagonist relation to cardiovascular disease risk in patients with rheumatoid arthritis (2022) (4)
- No evidence of association of the KLF12 gene with rheumatoid arthritis in Spanish and Dutch cohorts and a meta-analysis of published data. (2011) (4)
- Interstitial keratitis secondary to severe hidradenitis suppurativa responding to adalimumab. (2012) (4)
- Biologic Therapy in COVID-19 (2020) (4)
- Audiovestibular Manifestations in Systemic Vasculitis: An Update (2011) (4)
- Implication of new atherosclerotic carotid plaques in the cardiovascular outcome of patients with rheumatoid arthritis (2012) (4)
- Long-term rheumatoid arthritis and endothelial dysfunction. (2004) (4)
- Effects of disease activity on lipoprotein levels in patients with early arthritis: can oxidized LDL cholesterol explain the lipid paradox theory? (2020) (4)
- [Arthritis reactive to Giardia lamblia]. (1992) (4)
- The Functional Polymorphism 844 A>G in FcαRI (CD89) Does Not Contribute to Systemic Sclerosis or Rheumatoid Arthritis Susceptibility (2011) (4)
- OP0339 TOCILIZUMAB IN GIANT CELL ARTERITIS. MONOTHERAPY VERSUS COMBINED WITH CONVENTIONAL IMMUNOSUPPRESSIVE DRUGS (2019) (4)
- Subclinical aortitis after starting nivolumab in a patient with metastatic melanoma. A case of drug-associated aortitis? (2018) (4)
- HLA-DRB1 associations in biopsy proven erythema nodosum. (2001) (4)
- Role of VEGF Polymorphisms in the Susceptibility and Severity of Interstitial Lung Disease (2021) (4)
- [Behcet syndrome and peripheral neuropathy as a possible new minor criterion]. (1991) (4)
- articleA 1298 C polymorphism in the MTHFR gene predisposes to cardiovascular risk in rheumatoid arthritis (2010) (4)
- Role of asymptomatic hyperuricemia and serum uric acid levels in the pathogenesis of subclinical atherosclerosis in psoriatic arthritis: comment on the article by Chen et al. (2009) (4)
- Role of BANK1 Gene Polymorphisms in Biopsy-proven Giant Cell Arteritis (2010) (4)
- Association of FCGR 2 A and FCGR 2 A-FCGR 3 A haplotypes with susceptibility to giant cell arteritis (2015) (4)
- [Collagenous colitis associated with rheumatoid arthritis]. (1991) (4)
- Identi fi cation of the PTPN 22 functional variant R 620 W as susceptibility genetic factor for giant cell arteritis (2013) (4)
- Relative Risk Chart Score for the Assessment of the Cardiovascular Risk in Young Patients with Ankylosing Spondylitis (2018) (4)
- Correction: Identification of Novel Genetic Markers Associated with Clinical Phenotypes of Systemic Sclerosis through a Genome-Wide Association Strategy (2011) (3)
- The role of a functional variant of TYK2 in vasculitides and infections. (2020) (3)
- Dysfunction of myoplasmic Ca2+ regulation in skeletal muscle from predialytic uremic patients. (1995) (3)
- Investigation of TLR 5 and TLR 7 as candidate genes for susceptibility to systemic lupus erythematosus (2006) (3)
- Prevalence of Comorbidities in Rheumatoid Arthritis and Evaluation of Their Monitoring in Clinical Practice: The Spanish Cohort of the COMORA Study (2019) (3)
- Cardiovascular and disease-related features associated with extra-articular manifestations in axial spondyloarthritis. A multicenter study of 888 patients. (2022) (3)
- [Neuro-Behçet: a follow-up of 4 cases treated with chlorambucil]. (1995) (3)
- Additional proposals to reduce comorbidity in patients with chronic inflammatory rheumatic diseases: comment on ‘Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiative’ by Baillet et al (2016) (3)
- [Ear, nose and throat manifestations of Wegener's granulomatosis (granulomatosis with polyangiitis)]. (2012) (3)
- Low back pain as presenting manifestation of giant cell arteritis associated to abdominal aortitis. (2007) (3)
- Single-nucleotide polymorphisms at the 9p21.3 genomic region not associated with the risk of cardiovascular disease in patients with rheumatoid arthritis. (2013) (3)
- Analysis of six tetranucleotide polymorphisms of the X-chromosome in different Spanish regions (2006) (3)
- A TNFSF13B functional variant is not involved in systemic sclerosis and giant cell arteritis susceptibility (2018) (3)
- Endothelin-1 serum levels in women with Rheumatoid Arthritis. (2019) (3)
- Lack of association between ICAM-1 gene polymorphisms and biopsy-proven erythema nodosum. (2004) (3)
- [Reactive arthritis and infestation by Giardia lamblia]. (1991) (3)
- Experts document on methotrexate use in combined therapy with biological or targeted synthetic disease modifying drugs in patients with rheumatoid arthritis. (2020) (3)
- Rituximab in Takayasu arteritis: an unmet hope. (2018) (3)
- Machine Learning for the Identification of a Common Signature for Anti–SSA/Ro 60 Antibody Expression Across Autoimmune Diseases (2022) (3)
- THU0219 Beneficial effect of anti-il-6 blockade on insulin resistance and insulin sensitivity in patients with rheumatoid arthritis (2018) (3)
- Validation of the Spanish version of the fibromyalgia rapid screening tool to detect fibromyalgia in primary care health centres. (2016) (3)
- The role of PET/CT in the evaluation of patients with large-vessel vasculitis: useful for diagnosis but with potential limitations for follow-up. (2022) (2)
- Disparate results in studies of adalimumab in the treatment of hidradenitis suppurativa: comment on the article by Amano et al (2013) (2)
- The impact of the metabolic syndrome on cardiovascular risk and disease in rheumatoid arthritis (2008) (2)
- FRI0612 IMMUNE-RELATED ADVERSE EVENTS ASSOCIATED WITH IMMUNOTHERAPY. LONG-TERM FOLLOW-UP OF 102 PATIENTS FROM A REFERRAL SINGLE CENTER (2019) (2)
- THU0087 Subclinical Carotid Atherosclerosis in Rheumatoid Arthritis: Role of Serum Cathepsin S and Cystatin C (2016) (2)
- Functional Variants of Fc Gamma Receptor (FCGR2A) and FCGR3AAre Not Associated with Susceptibility to Systemic Sclerosis in a Large European Study (EUSTAR) (2011) (2)
- Amylin serum levels are upregulated in patients with systemic lupus erythematosus. (2021) (2)
- Lack of Association Between IRF5 Gene Polymorphisms and Biopsy-proven Giant Cell Arteritis (2010) (2)
- Misperception of the Cardiovascular Risk in Patients with Rheumatoid Arthritis (2020) (2)
- Influence of IL17A gene on the pathogenesis of immunoglobulin-A vasculitis. (2020) (2)
- BAFF, APRIL and BAFFR on the pathogenesis of Immunoglobulin-A vasculitis (2021) (2)
- The angiopoietin-like protein 4, apolipoprotein C3, and lipoprotein lipase axis is disrupted in patients with rheumatoid arthritis (2022) (2)
- Lack of association between flow-mediated endothelium-dependent vasodilatation and biomarkers of endothelial dysfunction in patients with severe rheumatoid arthritis (2012) (2)
- HLA-DRB1 associations in systemic lupus erythematosus patients from northwest Spain. (2001) (2)
- Osteopontin and interleukin-6 as biomarkers of interstitial lung disease (2020) (2)
- Association study of BAK1 gene polymorphisms in Spanish rheumatoid arthritis and systemic lupus erythematosus cohorts (2011) (2)
- SAT0127 The efficacy of tofacitinib in patients with rheumatoid arthritis stratified by baseline body mass index (2018) (2)
- Vascular endothelial growth factor haplotypes are associated with severe ischaemic complications in giant cell arteritis regardless of the disease phenotype. (2021) (2)
- Role of carotid ultrasonography in the evaluation of cardiovascular risk in patients with rheumatoid arthritis (2010) (2)
- CXCL5 gene polymorphism association with diabetes mellitus. (2008) (2)
- Lack of association between IFNGR1 gene polymorphisms and biopsy-proven giant cell arteritis. (2010) (2)
- Insulin Resistance Is Not Increased in Inflammatory Bowel Disease Patients but Is Related to Non-Alcoholic Fatty Liver Disease (2021) (2)
- Erratum to “Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: Baseline data of the CARMA Project” [Semin Arthritis Rheum 44 (2015) 618–626] (2015) (2)
- Biologic Therapy in Refractory Non-Multiple Sclerosis Optic Neuritis Isolated or Associated to Immune-Mediated Inflammatory Diseases. A Multicenter Study (2020) (2)
- Association of STAT4 gene with rheumatoid arthritis (2008) (2)
- Etanercept-induced hypertriglyceridemia during the treatment of recurrent aphthous stomatitis. (2013) (2)
- Role of MUC1 rs4072037 polymorphism and serum KL-6 levels in patients with antisynthetase syndrome (2021) (2)
- Potential relation of cardiovascular risk factors to disease activity in patients with axial spondyloarthritis (2021) (2)
- Influence of IL2RA rs2104286 Polymorphism in the Risk of Biopsy-proven Giant Cell Arteritis (2010) (2)
- Rheumatoid arthritis and anti-TNF-alpha therapy. (2005) (2)
- Association Between Homocysteine Serum Level and Bone Mineral Density in Patients With Rheumatoid Arthritis. (2019) (2)
- Obesity and response to biological therapy in rheumatoid arthritis: the role of body mass index and adipose tissue cytokines. (2021) (2)
- Intravenous methylprednisolone induces rapid improvement in non-infectious uveitis: a multicentre study of 112 patients. (2021) (2)
- Asprosin in health and disease, a new glucose sensor with central and peripheral metabolic effects (2023) (2)
- E064 The relationship between lipid profile changes and inflammation across the Phase 3 sarilumab rheumatoid arthritis (RA) development programme (2019) (2)
- Role of the IL33 and IL1RL1 pathway in the pathogenesis of Immunoglobulin A vasculitis (2021) (2)
- H2-A polymorphism contributes to H2-Eβ-mediated protection in collagen-induced arthritis (2007) (2)
- ESICM LIVES 2016: part one (2016) (2)
- Association of apolipoprotein B/apolipoprotein A1 ratio and cardiovascular events in rheumatoid arthritis: results of the CARMA study. (2019) (2)
- Histopathologic differences between cutaneous vasculitis associated with severe bacterial infection and cutaneous vasculitis secondary to other causes: study of 52 patients. (2016) (2)
- Predicting the risk of relapse in polymyalgia rheumatica: novel insights (2021) (2)
- H2-A polymorphism contributes to H2-Eβ-mediated protection in collagen-induced arthritis (1996) (2)
- Idiopathic chronic polyserositis with massive ascites responding to colchicine in an adult: A case report (2014) (2)
- Role of fibroblast growth factor-23 in calcinosis in women with systemic sclerosis. (2020) (2)
- Vitamin D levels and response to biphosphonates in postmenopausal women receiving glucocorticoid therapy (2014) (2)
- The Performance of Vascular Age in the Assessment of Cardiovascular Risk of Patients with Rheumatoid Arthritis (2020) (2)
- Analysis of the influence of the ghrelin receptor rs509035, rs512692 and rs2922126 polymorphisms in the risk of cardiovascular disease in patients with rheumatoid arthritis. (2011) (2)
- Comparable effects of traditional cardiovascular risk factors on subclinical atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis. (2020) (2)
- Interleukin-1 receptor antagonist gene polymorphism in patients with biopsy-proven erythema nodosum. (2010) (1)
- Lack of Association Between TLR 4 rs 4986790 Polymorphism and Risk of Cardiovascular Disease in Patients with Rheumatoid Arthritis (2012) (1)
- AB0293 ASSOCIATION OF HOMOCYSTEINE WITH BONE MINERAL DENSITY IN RHEUMATOID ARTHRITIS PATIENTS (2019) (1)
- The use of carotid ultrasonography in the assessment of subclinical atherosclerosis and the paradoxical effect of corticosteroids on atherosclerosis in patients with rheumatoid arthritis. (2009) (1)
- Why is Rheumatoid Arthritis Mortality Still High Despite the Advent of New Therapies? Comment on the Article by Widdifield et al (2016) (1)
- Cardiovascular risk assessment in rheumatoid arthritis: What goals should be achieved? (2015) (1)
- Respiratory syncytial virus infection in a patient with systemic lupus erythematosus (1994) (1)
- [Seronegative systemic lupus erythematosus and autoimmune thyroiditis]. (1993) (1)
- Pleural and pericardial effusion as the only manifestation of IgG4-related disease (2020) (1)
- Disease activity in patients with rheumatoid arthritis increases serum levels of apolipoprotein C-III. (2021) (1)
- Response to ‘Adipokines, inflammation, insulin resistance, and carotid atherosclerosis in patients with rheumatoid arthritis’ (2014) (1)
- SAT0170 Anti-il-6 therapy modulates leptin in patients with rheumatoid arthritis (2018) (1)
- [Paraneoplastic polyarthritis. Description of 5 cases]. (1987) (1)
- SAT0540 Treatment with intravenous immunoglobulin in the vasculitis anca positive. 27 cases studied in a single reference centre (2018) (1)
- Targeted nanotherapy with everolimus reduces inflammation and fibrosis in scleroderma‐related interstitial lung disease developed by PSGL‐1 deficient mice (2022) (1)
- FRI0452 Nailfold capillaroscopy in antisynthetase syndrome (NASCAR): results of a multicenter, international study of the american and european network of antisynthetase syndrome (AENEAS) (2018) (1)
- Is the Homeostatic Model Assessment of Insulin Resistance a Poor Predictor of Cardiovascular Disease in Rheumatoid Arthritis? Comment on the Article by Giles et al (2015) (1)
- Positron emission tomography/computed tomography in relapsing polychondritis. (2020) (1)
- IgA Vasculitis (Henoch-Schönlein Purpura) (2014) (1)
- AB0730 RECLASSIFICATION INTO VERY HIGH CARDIOVASCULAR RISK AFTER CAROTID ULTRASOUND IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS (2019) (1)
- Lack of Association Between the rs6920220 (G/A) Polymorphism of the 6q23 Region and Biopsy-proven Giant Cell Arteritis (2010) (1)
- [Cardiovascular disease in rheumatoid arthritis. Importance and clinical management]. (2009) (1)
- SAT0220 USE OF TOCILIZUMAB IN AORTITIS. A MULTICENTER STUDY OF 79 PATIENTS (2019) (1)
- Apolipoprotein C-III in patients with systemic lupus erythematosus (2022) (1)
- Serum Levels of Transforming Growth Factor Beta 1 in Systemic Lupus Erythematosus Patients (2022) (1)
- QRISK3 Performance in the Assessment of Cardiovascular Risk in Patients with Inflammatory Bowel Disease (2021) (1)
- [Post-streptococcal reactive arthritis versus rheumatic fever]. (1992) (1)
- Rheumatoid arthritis-etiology, pathogenesis and animal models (1)
- [Adult-onset Still's disease]. (2016) (1)
- Carotid ultrasound as predictor of atherosclerosis in rheumatoid arthritis. (2012) (1)
- Implication of CXCL 5 ( epithelial neutrophil-activating peptide 78 ) in the development of insulin resistance in patients with rheumatoid arthritis (2019) (1)
- AB0577 TOCILIZUMAB IN GIANT CELL ARTERITIS. ROUTE OF ADMINISTRACION: INTRAVENOUS OR SUBCUTANEOUS (2019) (1)
- O31 Integrative analysis reveals a molecular stratification of systemic autoimmune diseases (2020) (1)
- Elevated VCAM-1, MCP-1 and ADMA serum levels related to pulmonary fibrosis of interstitial lung disease associated with rheumatoid arthritis (2022) (1)
- P235 Glucocorticoid dose is progressively reduced in Patients with rheumatoid arthritis (RA) receiving sarilumab: results from the open label EXTEND study (2020) (1)
- Gastrointestinal involvement in adult IGA vasculitis. (2020) (1)
- Management of Cardiovascular Disease Risk in Rheumatoid Arthritis (2022) (1)
- Association between homocysteine levels and arterial stiffness in women with systemic sclerosis. (2020) (1)
- Apolipoprotein C3 and beta-cell dysfunction are linked in patients with systemic lupus erythematosus. (2021) (1)
- A Review of the Dermatological Complications of Giant Cell Arteritis (2021) (1)
- Re: Autoimmunity in sudden sensorineural hearing loss… by Cadoni et al (2003) (1)
- Lack of association between RETN rs 1862513 polymorphism and cardiovascular disease in patients with rheumatoid arthritis (2006) (1)
- Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis (2022) (1)
- Remission in palindromic rheumatism during pregnancy. (1993) (1)
- [Comparative study of von Willebrand factor in patients with temporal arteritis]. (1992) (1)
- THU0288 LONG-TERM FOLLOW-UP OF ANTI-IL6-RECEPTOR TOCILIZUMAB IN REFRACTORY UVEITIS IN PATIENTS WITH BEHÇET’S DISEASE. MULTICENTER STUDY OF 14 PATIENTS IN CLINICAL PRACTICE (2019) (1)
- Apolipoprotein C3 Is Downregulated in Patients With Inflammatory Bowel Disease (2022) (1)
- Detection of high cardiovascular risk patients with ankylosing spondylitis based on the assessment of abdominal aortic calcium as compared to carotid ultrasound (2018) (1)
- Altitude and giant cell arteritis. (2005) (1)
- SAT0535 Carotid Ultrasound in The Cardiovascular Risk Stratification of Patients with Ankylosing Spondylitis: Results of A Population-Based Study (2016) (1)
- Long-term survival of renal transplantation in patients with lupus nephritis: experience from a single university centre. (2021) (1)
- Serum leptin concentration is associated with the attainment of clinical outcomes in patients with axial spondyloarthritis treated with TNF inhibitors. (2022) (1)
- Atherosclerosis in ankylosing spondylitis: clinical implications. (2018) (1)
- FRI0604 SYSTEMIC SARCOIDOSIS. STUDY OF 381 PATIENTS FROM A TERTIARY UNIVERSITY HOSPITAL IN THE NORTH OF SPAIN (2019) (1)
- Alpha-Klotho protein in systemic lupus erythematosus. (2021) (1)
- THU0282 The impact of comorbidities on physical function in patients with ankylosing spondylitis (AS) and psoriatic arthritis (PSA) attending rheumatology clinics (2018) (1)
- SCORE2 Assessment in the Calculation of Cardiovascular Risk in Patients with Rheumatoid Arthritis (2021) (1)
- Experts document on methotrexate use in combined therapy with biological or targeted synthetic disease modifying drugs in patients with rheumatoid arthritis. (2022) (1)
- THU0121 CIRCULATING FIBROBLAST GROWTH FACTOR-23 IS ASSOCIATED WITH DYSLIPIDEMIA IN RHEUMATOID ARTHRITIS PATIENTS (2019) (0)
- THU0224 Anti-TNF-α Therapy Reduces Endothelial Cell Activation in Non-Diabetic Ankylosing Spondylitis Patients (2015) (0)
- Tocilizumab for rheumatoid arthritis: results of the Phase III clinical trial program (2011) (0)
- SAT0063 ASSOCIATION OF SMOKING WITH TRIPLE CONCORDANT SEROPOSITIVITY IN RA PATIENTS, AND WITH RHEUMATOID FACTOR IN THE REMAINING PATIENTS (2019) (0)
- Lymphocytes Overexpressing Human Bcl-2 in T Autoimmunity in Transgenic Mice T Cell-Dependent Inhibition of + CD 25 + CD 4 Izui (2007) (0)
- Efficacy of tofacitinib in patients with rheumatoid arthritis stratified by baseline body mass index: an analysis of pooled data from phase 3 studies (2022) (0)
- FRI0253 RENAL TRANSPLANTATION IN LUPUS NEPHRITISVS NON-AUTOIMMUNE TRANSPLANTATION. LONG TERM FOLLOW-UP. STUDY FROM A SINGLE TERTIARY CENTER (2019) (0)
- THU0566 OCULAR FEATURES IN 381 PATIENTS WITH SYSTEMIC SARCOIDOSIS AND ITS CORRELATION WITH THE IWOS CRITERIA. STUDY IN A UNIVERSITY HOSPITAL (2019) (0)
- SAT0081 Lack of Correlation Between Carotid Ultrasound and Disease Duration or Specific Features of Rheumatoid Arthritis (2015) (0)
- Point of view about biologic therapy in covid-19 (2020) (0)
- [Lupus myopathy refractory to steroid treatment]. (1991) (0)
- A185 Infrared thermal imaging of the hand during vascular occlusion in healthy volunteers (2016) (0)
- Cefuroxime axetil in the treatment of lower respiratory tract infections in patients with chronic lung diseases (1992) (0)
- THU0340 Rheumatoid Arthritis and Systemic Lupus Erythematosus Exhibit Similar Degree of Severity of Subclinical Atherosclerosis. Results from A Cross-Sectional Study in A Population of Northwestern Spain (2016) (0)
- Correction: SMAD3 rs17228212 Gene Polymorphism Is Associated with Reduced Risk to Cerebrovascular Accidents and Subclinical Atherosclerosis in Anti-CCP Negative Spanish Rheumatoid Arthritis Patients (2013) (0)
- Association of circulating calprotectin with lipid profile in axial spondyloarthritis (2018) (0)
- SAT0348 CLINICAL SPECTRUM TIME COURSE OF ANTISYNTHETASE SYNDROME PATIENTS POSITIVE FOR ANTICENTROMERE ANTIBODIES (2020) (0)
- The genetic contribution of inflammation to the increased risk of cardiovascular disease in rheumatoid arthritis. (2023) (0)
- University of Groningen Identification of Novel Genetic Markers Associated with Clinical Phenotypes of Systemic Sclerosis through a Genome-Wide Association Strategy Gorlova, (2011) (0)
- A Proof-of-Concept Analysis of Plasma-Derived Exosomal microRNAs in Interstitial Pulmonary Fibrosis Secondary to Antisynthetase Syndrome (2022) (0)
- [Meningococcal arthritis. Clinical presentation and serologic characteristics in 13 patients]. (1986) (0)
- WISP-2 modulates the induction of inflammatory mediators and cartilage catabolism in chondrocytes (2022) (0)
- SAT0346 Cutaneous Vasculitis Associated To Connective Tissue Diseases and Other Autoimmune Disorders. Study of 35 Patients from A Single Centre (2016) (0)
- Compared efficacy of rituximab, abatacept, and tocilizumab in patients with rheumatoid arthritis refractory to methotrexate or anti-TNF agents: a systematic review and network (2021) (0)
- [Adult Schonlein-Henoch syndrome with abdominal involvement refractory to steroid treatment]. (1990) (0)
- SAT0012 Proteinase K-Like Serine Protease PCSK9 Influence on the Dyslipidemia Observed in Rheumatoid Arthritis Patients (2015) (0)
- OP0169 LONG-TERM SURVIVAL IN LUNG TRANSPLANTATION FOR INTERSTITIAL LUNG DISEASE ASSOCIATED WITH CONECTIVE TISSUE DISEASES. STUDY OF 26 CASES OF A SINGLE CENTER (2019) (0)
- AB0755 Urticarial vasculitis: A clinical and histopathologic review (2013) (0)
- AB0316 Bone Mass, Osteoprotegerin and Vitamin D: Relation with Endothelial Dysfunction in Rheumatoid Arthritis Patients (2014) (0)
- WISP-2 modulates the induction of inflammatory mediators and cartilage catabolism in chondrocytes. (2022) (0)
- AB1301 Cardiovascular risk age and vascular age estimations in predicting cardiovascular events in rheumatoid arthritis patients (2018) (0)
- THU0081 Role of The Soluble Form of Dipeptydil Peptidase-4(DPP4) in The Insulin Resistance of Patients with Rheumatoid Arthritis (2016) (0)
- Treatment of migraine with monoclonal antibodies (2022) (0)
- FRI0477 SYSTEMIC TREATMENT IN SARCOIDOSIS. STUDY OF 377 PATIENTS FROM A SINGLE UNIVERSITY HOSPITAL (2020) (0)
- SAT0119 Comparison between Carotid Plaque and Carotid Intima Media Thickness To Detect Subclinical Atherosclerosis in Rheumatoid Arthritis (2016) (0)
- IgA Vasculitis: Influence of CD40, BLK and BANK1 Gene Polymorphisms (2022) (0)
- Acknowledgement to referees (2016) (0)
- AB0151 Factors associated with serum IL-6 levels in patients with early arthritis (2013) (0)
- [Paraneoplastic arthritis as the first manifestation of a hypernephroma]. (1992) (0)
- Cranial and extracranial large-vessel giant cell arteritis share a genetic pattern of interferon-gamma pathway. (2022) (0)
- A predominant involvement of the triple seropositive patients and others with rheumatoid factor in the association of smoking with rheumatoid arthritis (2020) (0)
- AB1098 COMPARISON OF THE PERFORMANCE OF CLASSIFICATION/DIAGNOSTIC CRITERIA FOR POLYMYALGIA RHEUMATICA. SINGLE CENTERSTUDY OF 100 PATIENTS (2019) (0)
- A genome-wide association study suggests the HLA Class II region as the major susceptibility locus for IgA vasculitis (2017) (0)
- FRI0277 ISCHEMIC AND SYSTEMIC SYMPTOMS IN GIANT CELL ARTERITIS PATIENTS, RESPONSE TO TOCILIZUMAB (2019) (0)
- Progranulin in Musculoskeletal Inflammatory and Degenerative Disorders, Focus on Rheumatoid Arthritis, Lupus and Intervertebral Disc Disease: A Systematic Review (2022) (0)
- FRI0291 RENAL TRANSPLANTATION DUE TO RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS (RPGN). COMPARATIVE STUDY WITH NON-AUTOIMMUNE TRANSPLANTATION AND LONG-TERM FOLLOW-UP. STUDY FROM A SINGLE TERTIARY CENTER (2019) (0)
- Transforming growth factor beta 1 is associated with subclinical carotid atherosclerosis in patients with systemic lupus erythematosus (2023) (0)
- A CROSS-DISEASE META-GWAS IDENTIFIES IRF1, STAT3 AND ZBTB9-BAK1 AS NEW SHARED SUSCEPTIBILITY LOCI IN SYSTEMIC SCLEROSIS AND CROHN¿S DISEASE (2019) (0)
- Role of IRF5 in the pathogenesis of immunoglobulin-A vasculitis. (2020) (0)
- Subclinical Atherosclerosis in Ankylosing Spondylitis (2011) (0)
- Is the extracranial large vessel giant cell arteritis still missing from the new 2022 ACR/EULAR classification criteria? (2023) (0)
- THU0438 Comparative study of infliximab versus adalimumab in refractory uveitis associated to cystoid macular oedemadue to behÇet’s disease. mulcitenter study of 40 cases (2018) (0)
- Endothelial nitric oxide synthase polymorphisms in biopsy-proven erythema nodosum from a defi ned population (2006) (0)
- A case-control study suggests that the CCR 6 locus is not involved in the susceptibility to giant cell arteritis (2006) (0)
- AB0111 THE ROLE OF KLOTHO IN RHEUMATOID ARTHRITIS (2019) (0)
- FRI0006 PROTECTIVE ROLE OF THE PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) RS2495477 POLYMORPHISM IN PATIENTS WITH RHEUMATOID ARTHRITIS AND SUBCLINICAL ATHEROSCLEROSIS (2019) (0)
- INFLAMMATION AND HOST RESPONSE TO INFECTION CARD8 rs2043211 (p.C10X) Polymorphism Is Not Associated with Disease Susceptibility or Cardiovascular Events in Spanish Rheumatoid Arthritis Patients (2012) (0)
- SAT0491 Clinical features and complications in a large international cohort of antimda5 patients: a challenge for the future (2018) (0)
- SAT0129 Kidney Function, Endothelial Activation and Atherosclerosis in Black and White Africans with Rheumatoid Arthritis (2015) (0)
- Reply to: Comment on: Reclassification into very-high cardiovascular risk in psoriatic arthritis as well as axial spondyloarthritis. (2020) (0)
- [Polyarteritis nodosa in a woman with temporal arteritis]. (1992) (0)
- Severe microscopic polyangiitis limited to the skin. (2021) (0)
- SAT0150 Cutaneous Vasculitis Secondary to Drugs. Descriptive Study of 232 Patients (2013) (0)
- Publisher Correction: A predominant involvement of the triple seropositive patients and others with rheumatoid factor in the association of smoking with rheumatoid arthritis (2020) (0)
- SAT0506 KAWASAKI DISEASE AND CARDIOVASCULAR OUTCOMES IN THE LAST 25 YEARS. STUDY OF 55 PATIENTS FROM A REFERAL HOSPITAL IN THE NORTH OF SPAIN (2019) (0)
- [Pneumothorax in rheumatoid arthritis as a factor of poor prognosis]. (1991) (0)
- AB0034 The C allele of the single nucleotide polymorphism RS2228145 in the IL6 receptor gene is associated with higher levels of serum oxidised LDL in early arthritis patients (2013) (0)
- FRI0215 RESPONSE TO TOCILIZUMAB IN LARGE VESSEL VASCULITIS ACCORDING TO THE EXTENT OF BASELINE 18F-FDG VASCULAR UPTAKE (2020) (0)
- Role of adiponectin in non-diabetic patients with rheumatoid arthritis undergoing anti-IL-6 therapy. (2021) (0)
- Sex disparities in systemic lupus erythematosus in Northwestern Spain are not due to ethnic diversity (2015) (0)
- [Common variable immunodeficiency and polyarthritis: a case report]. (1993) (0)
- FRI0276 TIME OF DISEASE EVOLUTION AND EFFICACY OF TOCILIZUMAB IN GIANT CELL ARTERITIS (2019) (0)
- FRI0038 HERPES ZOSTER IN RHEUMATOID ARTHRITIS. PROSPECTIVE SINGLE CENTER STUDY OF 390 RA PATIENTS FOR 5YEARS (2019) (0)
- Endothelin-1 as a Biomarker of Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Associated with Autoimmune Diseases (2023) (0)
- Apolipoprotein C-III is linked to the insulin resistance and beta-cell dysfunction that are present in rheumatoid arthritis (2022) (0)
- Polymyalgia rheumatica: when should we suspect an underlying large vessel vasculitis? (2023) (0)
- FRI0625 Different strategies to implement the eular guideline for cardiovascular risk management in daily practice (2018) (0)
- Association of Human Leukocyte Antigens Class II Variants with Susceptibility to Hidradenitis Suppurativa in a Caucasian Spanish Population (2020) (0)
- Images in clinical medicine. Cold hands associated with scleroderma. (2013) (0)
- . 2 from Northwestern Spain C-Reactive Protein Gene Polymorphisms in Biopsy-proven Giant Cell Arteritis (2009) (0)
- Full characterization of the three pathways of the complement system in patients with systemic lupus erythematosus (2023) (0)
- Proprotein Convertase Subtilisin/Kexin Type 9 in the Inflammation-Related Dyslipidemia of Patients with Axial Spondyloarthritis is Related to Disease Activity. (2020) (0)
- Immunochip data of four autoimmune diseases reveals novel single-disease and cross-phenotype associations Coeliac (2018) (0)
- THU0056 Impaired beta cell signaling is present in non diabetic rheumatoid arthritis patients (2013) (0)
- Correction: Ferraz-Amaro et al. SCORE2 Assessment in The Calculation of Cardiovascular Risk in Patients with Rheumatoid Arthritis. Diagnostics 2021, 11, 2363 (2022) (0)
- Reply to comment on: Alpha-Klotho protein in systemic lupus erythematosus. (2023) (0)
- Comment on: Proprotein convertase subtilisin/kexin type 9 in the dyslipidaemia of patients with axial spondyloarthritis is related to disease activity: reply. (2021) (0)
- Variant for Rheumatoid Arthritis in the 1 p 13 . 2 Region R 620 W Polymorphism As the Sole Common Risk PTPN 22 Evidence for (2011) (0)
- AB0007 The CD226 gene is not involved in giant cell arteritis in the spanish caucasian population (2013) (0)
- AB0022 Influence of mhciita RS3087456 and RS4774 polymorphisms in the susceptibility to cardiovascular disease of patients with rheumatoid arthritis (2013) (0)
- SAT0219 EFFICACY AND SAFETY OF TOCILIZUMAB IN GIANT CELL ARTERITIS INDEPENDENTLY OF THE INICIAL PREDNISONE DOSE (2019) (0)
- Effect of cardiovascular disease on chronic inflammatory joint disease: reverse causality? (2020) (0)
- Psoriasis of the external auditory canal: prevalence, clinical features and impact on quality of life (2022) (0)
- ¿Idiopathic pulmonary fibrosis or interstitial lung disease associated to connective tissue diseases? Endothelial progenitor cells as a potential tool for the differential diagnosis (2020) (0)
- AB0277 Comparison between Intima-Media Thickness and Coronary Artery Tomography in Subclinical Atherosclerosis Detection in Rheumatoid Arthritis (2016) (0)
- Vitamin D and autoimmune rheumatic diseases. (2016) (0)
- Circulating interleukin-6 and cardiovascular disease risk in patients with rheumatoid arthritis with low disease activity due to active therapy. (2022) (0)
- A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease (2020) (0)
- AB0030 The LP13.3 genomic region -RS599839- is associated with endothelial dysfunction in patients with rheumatoid arthritis (2013) (0)
- FRI0646 EFFECT OF LONG-TERM MEDIUM-DOSE STEROID TREATMENT ON 18F-FDG PET/CT FINDINGS TO ASSESS VASCULAR AND MUSCULOESKELETAL INVOLVEMENT IN PATIENTSWITH POLYMYALGIA REUMATICA (2019) (0)
- [Usefulness of non-steroidal anti-inflammatory agents in the treatment of temporal arteritis]. (1992) (0)
- No evidence for association between the CCR5/Delta32CCR5 polymorphism and systemic sclerosis. (2011) (0)
- The of Rheumatology Are Not Associated with Susceptibility to Systemic Sclerosis in a Large European Correction: Functional Variants of Fc Gamma Receptor (FCGR2A) and FCGR3A (2010) (0)
- Systemic Sclerosis susceptibility or phenotype polymorphism does not confirm association with -945 promoter CTGF A large multicenter analysis of (2009) (0)
- Erratum to “Novel association of acid phosphatase locus 1*C allele with systemic lupus erythematosus” [Human Immunology 73 (2012) 107–110] (2012) (0)
- Lack of association between endothelial nitric oxide synthase polymorphisms and cutaneous vasculitis (2003) (0)
- Manifestations of Biopsy-proven Giant Cell Arteritis rs 1883832 Polymorphism in Susceptibility to and Clinical CD 40 Influence of 1 (2010) (0)
- erythema nodosum. Lack of association between ICAM-1 gene polymorphisms and biopsy-proven (2017) (0)
- Obesity and Osteoarthritis: Are Adipokines Bridging Metabolism, Inflammation, and Biomechanics? (2020) (0)
- AB0093 Association of cd247 polymorphisms with rheumatoid arthritis: a replication study and a meta-analysis (2013) (0)
- Serum Levels of Lipoprotein Lipase Are Increased in Patients with Inflammatory Bowel Disease (2023) (0)
- THU0581 BIOLOGICAL THERAPY IN NON ISCHAEMIC OPTIC NEURITIS ASSOCIATED TO IMMUNE-MEDIATED INFLAMMATORY DISEASES. MULTICENTER STUDY (2019) (0)
- SAT0124 MOLECULAR CHARACTERIZATION OF THE SERUM PROFILE ASSOCIATED TO THE INCREASED CARDIOVASCULAR RISK IN RHEUMATOID ARTHRITIS PATIENTS. EFFECTS OF BIOLOGICAL DRUGS. (2019) (0)
- THU0079 HDL, IGG anti-HDL Antibodies and PON1 Axis in Rheumatoid Arthritis Patients: A New Target for CV Disease (2016) (0)
- Chapter 24 Danazol Therapy (2008) (0)
- [Churg-Strauss allergic granulomatous vasculitis: pulse therapy with cyclophosphamide as an alternative treatment]. (1991) (0)
- THU0292 EXTRACRANIAL VESSEL INVOLVEMENT IN PATIENTS WITH GIANT CELL ARTERITIS (2019) (0)
- FRI0322 INSULIN RESISTANCE IN NON-DIABETES PATIENTS WITH SPONDYLOARTHRITIS (2020) (0)
- Heme oxygenase-1 promoter polymorphisms do not influence susceptibility to systemic sclerosis and its clinical phenotypes. (2013) (0)
- SCORE2 versus SCORE in patients with systemic lupus erythematosus (2022) (0)
- AB0612 TEMPORAL ARTERY BIOPSYIN GIANT CELL ARTERITIS. INTERRELATION OF INFLAMMATORY PATTERNS WITH ANALYTICAL DATA AND CLINICAL MANIFESTATIONS (2019) (0)
- SAT0512 LONG-TERM FOLLOW-UP OF CARDIOVASCULAR OUTCOMES IN KAWASAKI DISEASE. OBSERVATIONAL STUDY FROM A SINGLE CENTER (2019) (0)
- THU0584 RHEUMATOLOGICAL IMMUNE-RELATED ADVERSE EVENTS ASSOCIADTED WITH IMMUNOTHERAPY IN SOLID ORGAN TUMOR. STUDY OF 102 CASES FROM A REFERRAL SINGLE CENTER FOR LAST 4 YEARS (2019) (0)
- LILRA3 deficiency is not involved in the giant cell arteritis and systemic sclerosis predisposition. (2016) (0)
- Protein tyrosine phosphatase non-receptor 22 and C-Src tyrosine kinase genes are down-regulated in patients with rheumatoid arthritis (2017) (0)
- FRI0050 Differential Expression of OPG/RANKL/TRAIL System in Rheumatoid Arthritis (2016) (0)
- [Idiopathic granulomatous myopathy. An evolutionary study]. (1991) (0)
- Chapter 13 Henoch-Schönlein Purpura (2007) (0)
- AB0304 Utility of Relative Cardiovascular Risk and Vascular AGE in Reumathoid Arthritis Patients under 50 Years of Age (2014) (0)
- AB0014 Lack of Association between AB0, PPAP2B, ADAMST7, PIK3CG, EDNRA and Carotid Intima-Media Thickness, Carotid Plaques and Cardiovascular Disease in Patients with Rheumatoid Arthritis (2014) (0)
- Two coincidental neurological complications as a presenting form of infectious endocarditis. (2007) (0)
- AB0242 SURVIVAL ANALYSIS IN THE DEVELOPMENT OF SERIOUS INFECTIONS AND SERIOUS RESPIRATORY INFECTIONS IN AR PATIENTS INCLUDED IN A VACCINATION PROGRAM (2020) (0)
- Co-occurrence of giant cell arteritis in patients with polymyalgia rheumatica. Comment on the article by Nielsen AW, et al. (2022) (0)
- SAT0120 Comparison between Carotid Ultrasonography and Coronary Artery Calcification Score To Detect Subclinical Atherosclerosis in Rheumatoid Arthritis (2016) (0)
- THU0313 COMPARATIVE STUDY OF CLINICAL, ANALYTICAL AND VASCULAR 18F-FDG UPTAKE EVOLUTION IN PATIENTS WITH GIANT CELL ARTERITIS TREATED WITH METHOTREXATE VS TOCILIZUMAB (2019) (0)
- Treatment With Tofacitinib in Refractory Psoriatic Arthritis: A National Multicenter Study of the First 87 Patients in Clinical Practice (2021) (0)
- Omentin: a biomarker of cardiovascular risk in individuals with axial spondyloarthritis (2020) (0)
- OP0304 GENETIC AND FUNCTIONAL STUDY OF OMENTIN REGARDING CARDIOVASCULAR RISK IN AXIAL SPONDYLOARTHRITIS (2019) (0)
- Genome-wide pathway analysis identifies oxidative stress related gene MSRA as rheumatoid arthritis susceptibility locus (2010) (0)
- SAT0568 PERSISTENT VASCULAR 18F-FDG UPTAKE DESPITE CLINICAL-ANALYTICAL REMISSION IN PATIENTS WITH LARGE VESSEL VASCULITIS UNDER TOCILIZUMAB THERAPY. SINGLE UNIVERSITARY CENTER EXPERIENCE OF 30 PATIENTS. (2020) (0)
- AB0725 Anti-Tnf-α Therapy Improves Endothelial Function and Arterial Stiffness in Patients with Moderate-To-Severe Psoriasis: A 6-Month Prospective Study (2016) (0)
- SAT0017 The C allele of RS2228145 polymorphism in the gene of IL6 receptor alpha chain may predict a worse clinical outcome in patients with early arthritis (2013) (0)
- Cardiovascular disease in rheumatoid arthritis. Importance and clinical management (2009) (0)
- Meta-analysis of Immunochip data of four autoimmune diseases reveals novel single-disease and cross-phenotype associations (2018) (0)
- Cranial and extracranial giant cell arteritis do not exhibit differences in the IL6 -174 G/C gene polymorphism. (2022) (0)
- J.L. Fernández-Sueiro 1 , (2004) (0)
- Meta-analysis of Immunochip data of four autoimmune diseases reveals novel single-disease and cross-phenotype associations (2018) (0)
- [Calcinosis. Limited systemic sclerosis (CREST syndrome)]. (2009) (0)
- THU0150 INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. WHAT DO WE DON’T KNOW? THE LIRA STUDY (LUNG INVOLVEMENT IN RHEUMATOID ARTHRITIS). (2020) (0)
- Meta-analysis of Immunochip data of four autoimmune diseases reveals novel single-disease and cross-phenotype associations (2018) (0)
- Therapeutic update in large vessel vasculitides (2013) (0)
- P247 Carotid Plaque Assessment reclassifies patients with Inflammatory Bowel Disease into Very-High Cardiovascular Risk (2021) (0)
- Pleural and Pericardial Effusion as the Only Manifestation of IgG4-Related Disease. (2020) (0)
- Performance of Cardiovascular Risk Age and Vascular Age Estimations in Predicting Cardiovascular Events in Rheumatoid Arthritis (2017) (0)
- SAT0016 Role of PCR, GCKR, HNF1A, LEPR, ASCL1 and NLRP3 in Atherosclerosis in Patients with Rheumatoid Arthritis (2016) (0)
- AB0013 Lack of Association between IL6 Gene and Henoch-SchÖNlein Purpura (2014) (0)
- [Multiple myeloma, atypical presentation]. (1991) (0)
- SAT0109 SMOKING CESSATION IN PATIENTS WITH RA IS ASSOCIATED WITH REDUCED CVD EVENT RATES AND IMPROVED LIPID PROFILES AND PREDICTS LOWER RA DISEASE ACTIVITY (2019) (0)
- Disease Activity Is More Associated with IL-1 Than with IL-6 in Patients with Rheumatoid Arthritis (2022) (0)
- Acute monoarthritis as presenting manifestation of acute Q fever: report of a new case and literature review. (2013) (0)
- AB0586 Short and Long-Term Anti-TNF-Alpha Therapy in Refractory Uveitis. Study of 40 Adult Patients from A Single Universitary Center (2014) (0)
- Role of vascular endotelial growth factor polymorphisms in interstitial lung disease (2019) (0)
- A Genome-Wide Association Study Identifies Plasminogen and P4HA2 as Novel Susceptibility Genes for Giant Cell Arteritis (2017) (0)
- Trial of Tocilizumab in Giant-Cell Arteritis. (2017) (0)
- Oral anticoagulant treatment in rheumatoid arthritis patients with atrial fibrillation results of an international audit (2022) (0)
- SAT0523 Evolution of visual affection in patients with giant cell arteritis treated with tocilizumab (2018) (0)
- Identification of new risk loci shared across systemic vasculitides points towards potential target genes for drug repurposing (2023) (0)
- AB0294 THE EFFECT OF SMOKING ON ENDOTHELIN-1 IN PATIENTS WITH RHEUMATOID ARTHRITIS (2019) (0)
- Timing of Onset and Cluster with Other Manifestations Influence the Spectrum of Arthritis in Anti Jo-1 Positive Antisynthetase Syndrome: Results from a Multicenter, International, Retrospective Study (2015) (0)
- [Ehlers-Danlos's syndrome type II. A family study]. (1992) (0)
- FRI0250 SUBCLINICAL ATHEROSCLEROSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS: COMPARABLE EFFECT OF TRADITIONAL CARDIOVASCULAR RISK FACTORS WITH RHEUMATOID ARTHRITIS (2019) (0)
- Vascular Endothelial Growth Factor and Its Soluble Receptor in Systemic Lupus Erythematosus Patients (2022) (0)
This paper list is powered by the following services: